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ABSTRACT 
The American College of Cardiology (ACC) and the American Heart Association (AHA) (2013; 
2016), as well as the American Diabetes Association (ADA) joined forces to create clinical 
practice guidelines (CPGs) recommendations for healthcare providers (HCPs) to follow with the 
aim of preventing cardiovascular disease (CVD). Cardiovascular disease is the leading cause of 
morbidity and mortality in the United States. The Centers for Disease Control (2017a) estimates 
CVD costs 325 billion dollars annually. Although CVD has an astronomical cost associated with 
it, CPG adherence continues to be an issue among HCPs and improvement is warranted. The 
purpose of this EBP project was to alter standard practice among HCPs, with the aim of 
improving adherence of CPGs through prescribing a statin and/or aspirin among patients who 
have been diagnosed with dyslipidemia, hypertension (HTN), and/or type 2 diabetes mellites 
(T2DM) and have a 10-year atherosclerotic cardiovascular disease (ASCVD) risk factor of 
greater than or equal to 7.5%, thereby potentially preventing primary CVD in these at-risk 
patients. The sample size (N = 3) included one physician and two nurse practitioners who have 
prescriptive authority. Kotter’s change model was used as the theoretical framework and the 
Promoting Action on Research Implementation in Health Services (PARiHS) model as the 
evidence-based practice model used to guide this project. An extensive literature search was 
performed, which generated 10 pieces of evidence that met the inclusion criteria for this EBP 
project. The interventions for this project included a multi-modal approach that included four 
strategies: (a) education, (b) computer-generated paper reminders, (c) visual cues and (d) 
feedback. A cross tabulation Chi-square analysis was used to determine the effectiveness of the 
four intervention strategies for improving adherence by HCPs with prescribing statins and/or 
aspirin for the primary prevention of CVD in at-risk adult patients. Results showed HCPs 
prescribed according to the CPGs for 59.4% (n = 139) of the patients. A combined statistically 
significant improvement between all phases of this EBP project for compliance showed (X2 = 
6.887, df = 2, p = 0.032).  
ix 
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CHAPTER 1 
INTRODUCTION 
Clinical practice guidelines (CPGs) have been created as recommendations for health 
care providers (HCPs) to follow to improve patient outcomes (Fox et al., 2015; Goff et al., 2013; 
Stone et al., 2013). In 2013, the American College of Cardiology (ACC) and American Heart 
Association (AHA) joined forces to create CPG recommendations to assess cardiovascular risk 
(Goff et al., 2013) and to develop blood cholesterol treatment recommendations to reduce 
ASCVD risks among adult patients (Stone et al., 2013). In 2015, the AHA and American 
Diabetes Association (ADA) updated their CPG recommendations for the prevention of primary 
and secondary cardiovascular events (Fox et al., 2015; Garza, Dols, & Gillespie, 2017; Goff, 
2014; Stone et al., 2013). These guidelines were endorsed in 2016 by the United States 
Preventive Services Task Force (USPSTF) (USPSTF, 2016). In 2017, several entities gathered 
to create new recommendations for blood pressure parameters for the prevention of primary 
CVD among at-risk adult patients (Whelton et al., 2018).  
These CPGs recommend that patients who meet one of the following criteria:  
1) Clinical ASCVD, 
2) Primary elevations of LDL-C great than or equal to 190 mg/dl, 
3) diabetes ages 40-75 years, with a LDL-C of 70-189 mg/dl and without clinical 
ASCVD or 
4) without clinical ASCVD or diabetes with a LDL-C 70-189 mg/dl and estimated 10 
year ASCVD risk great than or equal to 7.5% using the Pooled Cohort Equation 
(PCE) (Stone et al., 2013). 
5) One or more CVD risk factor (i.e., dyslipidemia, hypertension (HTN), diabetes, or 
smoking) and a 10-year estimated ASCVD risk factor great than or equal to 10% 
using the PCE (USPSTF, 2016). 
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6) Estimated ASCVD risk great than or equal to 10% using the PCE and systolic blood 
pressure (SBP) great than or equal to 130 mm HG or diastolic blood pressure (DBP) 
great than or equal to 80 mm HG (Whelton et al., 2018). 
would benefit from initiating a moderate or high intensity 3-hydroxy-3-methyl-glutaryl-coenzyme 
A reductase inhibitor (statin) (Fox et al., 2015; Stone et al., 2013) or aspirin (USPSTF, 2016). 
However, prior to prescribing, HCPs must consider the risk of statin and aspirin therapy side 
effects versus the benefits to patients. Although side effects exist, the benefits of statin therapy 
outweigh the risks (Bender, 2014). Therefore, HCPs must overcome barriers and comply with 
CPGs. 
Unfortunately, HCPs do not always adhere to the evidence-based CPGs created 
because of the following barriers: a) lack of knowledge (Jun, Kovner, & Stimpfel, 2016), b) too 
time consuming to implement (Barth et al., 2016; McKee et al., 2017), c) the CPGs are too long 
to read (Alexander, Li, Tonelli, & Guyatt, 2016), d) various recommendations (Barth et al., 
2016), and/or e) primary care physicians not having input into the creation of the CPGs 
(Alexander et al., 2016). It is vital for HCPs to implement and adhere to CPGs to improve patient 
outcomes (Barth et al., 2016; Hendrix, Downs, & Carroll, 2015; McKee et al., 2017). To 
overcome barriers, strategies have been created which include: a) education (Jeffery et al., 
2015), b) audits and feedback (Ivers et al., 2012), c) reminders in electronic medical records 
(EMR) (Garza et al., 2017; Shojania et al., 2009), d) computer-generated alerts (Arditi, Rege-
Walther, Durieux, & Burnand, 2017), e) paper prompts (Pantoja et al., 2014), and f) highlighted 
reminders on paper (Hendrix et al., 2015).  These strategies have and continue to be explored 
to evaluate the best interventions for HCPs when implementing evidence-based CPGs into 
practice.  
Doctor of nursing practice (DNP) prepared nurses have the unique opportunity to assist 
physicians and other HCPs in evaluating up to date evidence-based practices (EBPs) to utilize 
when providing care to patients. Doctor of nursing practice prepared nurses are positioned to 
PREVENTING PRIMARY CVD: CPG COMPLIANCE  3 
 
3 
 
create and adopt strategies to assist physicians with implementing CPGs, thereby improving 
patient outcomes. Because the prevalence and cost of treating CVD is at a record high in the 
United States (Healthy 2020, 2014), it is essential that DNP prepared family nurse practitioners 
(FNPs) have knowledge to recognize and treat the signs and symptoms of CVD. Family nurse 
practitioners must stay abreast of current evidence to prevent primary CVD in at-risk adult 
patients and follow the recommended guidelines while treating each patient as a unique 
individual. 
Background 
In the United States, CVD costs $325 billion annually (Healthy People 2020, 2014) and 
is the leading cause of morbidity and mortality regardless of race, ethnicity, or gender (Centers 
for Disease Control [CDC], 2017a; Healthy People 2020, 2014; National Heart, Lung, and Blood 
Institute [NHLBI], 2017). Therefore, a goal of Healthy People 2020 (2014) is to:  
Improve cardiovascular health and quality of life through prevention, detection, and treatment 
of risk factors for heart attack and stroke; early identification and treatment of heart attacks 
and strokes; prevention of repeat cardiovascular events; and reduction in deaths from 
cardiovascular disease (Healthy People 2020, 2014).  
Cardiovascular disease is an umbrella term, which includes heart disease and coronary 
heart disease (CHD) (NHLBI, 2017). Heart disease affects the structure and function of the 
heart (NHLBI, 2017) and can cause strokes, congenital heart defects, and peripheral artery 
disease (NHLBI, 2017). Hypertension, dyslipidemia, diabetes, smoking, excessive alcohol 
intake, obesity, unhealthy eating habits, sedentary lifestyle, age, and family history are all risk 
factors that contribute to primary CVD (CDC, 2012, 2017a; Healthy People 2020, 2014). It is 
essential that HCPs adhere to evidence-based CPGs to achieve primary prevention of CVD to 
reduce costs and improve patient outcomes.  
According to Fox et al. (2015), preventing primary CVD involves the proper management 
of five key components: (a) nutrition, (b) obesity, (c) blood glucose, (d) blood pressure, and (e) 
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cholesterol. Patients and HCPs must work collaboratively towards the following three goals: (a) 
maintain a hemoglobin A1C of less than or equal to 6.5%, which has been recommended as an 
acceptable level by the ADA, (b) maintain a SBP of less than or equal to 130 with a diastolic 
blood pressure (DBP) of less than or equal to 80, which has been noted as an acceptable level 
by the 8th Joint National Committee (JNC 8) Hypertension Guidelines (Whelton et al., 2018), and 
(c) maintain a low-density lipoprotein-cholesterol (LDL-C) of less than 70 mg/dl, which is based 
on the 2013 ACC and AHA guidelines (Fox et al., 2015; Stone et al., 2013).  
According to Bender (2014), it is unrealistic to think HCPs alone can combat chronic 
patient illnesses. Healthcare providers must educate adult patients, who are at-risk for primary 
CVD, about lifestyle modifications (i.e., obesity, weight loss, heart healthy diet, exercise, and 
smoking cessation) which are crucial to preventing primary CVD (Fox et al., 2015; Goff et al., 
2013; Jensen et al., 2014; Stone et al., 2013).  While education can assist in improving patient 
awareness, patients must take the initiative to modify their lifestyles (Fox et al., 2015; Jensen et 
al., 2014).  
Obesity is a major modifiable risk factor for dyslipidemia, HTN, T2DM, and CVD (Jensen 
et al., 2014). Therefore, it is critical to educate individuals who are overweight, with a body mass 
index (BMI) of 25.0 to 29.9 kg/m2 or obese with a BMI greater than 30 kg/m2, to alter their 
lifestyles to that of a heart healthy lifestyle because they are at a higher risk for morbidity and 
mortality (Jensen et al., 2014). Weight loss can be achieved by eating a healthy diet and 
incorporating intense exercise into one’s routine or through diet, medication, meal replacement, 
or bariatric surgery (Fox et al., 2015; Jensen et al., 2014).  
Modifying one’s diet is another strategy that can aid in reducing one’s risk of CVD. The 
Mediterranean Diet, Dietary Approaches to Stop Hypertension (DASH) diet, and the American 
Heart Association diet are diets recommended by CPGs to decrease risk factors for morbidity 
and mortality (Eckel et al., 2014; Fox et al., 2015). Consuming a low-salt, low-fat, low 
carbohydrate diet with increasing one’s fruit, vegetables, legumes, and whole grains intake 
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effectively improves blood glucose levels, blood pressure, and lipid levels (Eckel et al., 2014; 
Fox et al., 2015; Jensen et al., 2014; Stone et al., 2015). 
Exercise is an essential strategy for preventing primary CVD among at-risk adult patients 
(Fox et al., 2015). Intense physical activity, which occurs three or more times per week, for at 
least 40 minutes has aided in reducing one’s weight, waist circumference, blood glucose levels, 
lipid levels, and blood pressure (Fox et al., 2015; Jensen et al., 2014). Physical activity must be 
incorporated alongside a healthy diet to prevent CVD among at-risk adult patients (Fox et al., 
2015). 
Smoking tobacco is another modifiable risk factor associated with CVD (CDC, 2017a; 
Fox et al., 2015). Adult patients who quit smoking tobacco, though gain weight, have a greater 
chance of preventing primary CVD than individuals who continue smoking tobacco (Fox et al., 
2015).  
Although these risk factors are modifiable, individuals are generally not inclined to 
change their behavior to become healthier (Bender, 2014). Even with lifestyle modification, 
some patients remain at-risk for CVD and require pharmacological interventions to prevent 
dyslipidemia, HTN, and T2DM (Fox et al., 2015). Therefore, several strategies have been 
published to remind HCPs to implement CPG recommendations and have included: (a) using 
audit and feedback techniques (Ivers et al., 2012; Li, 2018), (b) utilizing computer-generated 
paper reminders (Arditi et al., 2017), (c) implementing electronic medical record alerts (Garza et 
al., 2017; Hendrix et al., 2015; Shojania et al., 2009), (d) incorporating manual paper prompts at 
point of care (Pantoja et al., 2014), and (e) using clinical decision support systems (CDSS) (Fiks 
et al., 2015; Rokstad, Rokstad, Holmen, Lehmann, & Assmus, 2013; Zahanova, Tsouka, 
Palmert, & Mahmud, 2017).  
Statement of the Problem 
Clinical practice guidelines are evidence-based recommendations created to assist 
HCPs when making decisions to improve patient outcomes (Goff et al., 2013; Fox et al., 2015, 
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Stone et al., 2013; Whelton et al., 2018). Unfortunately, evidence shows that barriers prevent 
HCPs from following CPGs. Common barriers that impact HCPs adherence to CPGs include: 
(a) lack of knowledge, (b) the length of CPGs, (c) the time consuming nature of CPG 
implementation, (d) the fact that primary care physicians (PCPs) are not always involved in 
creating CPGs, (e) the age of the provider, and (f) disagreement with CPGs (Alexander et al., 
2016; Barth et al., 2016; Jun et al., 2016; McKee et al., 2017). It is vital that HCPs are willing to 
accept and adhere to guidelines set forth by the governing bodies to prevent CVD among at-risk 
adult patients. Healthcare providers must become knowledgeable of the evidence available and 
be receptive to new and improved patient treatment options. 
Morbidity and mortality rates increase among patients who have been diagnosed with 
CVD (CDC 2012, 2017a). Therefore, it is essential that all precautions are taken to assure 
primary CVD is prevented among at-risk adult patients. The initial focus of lifestyle changes 
must be patient education to prevent CVD, which includes education about obesity, weight loss, 
heart healthy diet, exercise, and smoking cessation (Fox et al., 2015; Stone et al., 2015). 
Patients are not always compliant with the education received from HCPs (Bender, 2014). As a 
result, HCPs are inclined to initiate statin and/or aspirin therapy for the primary prevention of 
CVD in at-risk adult patients. 
Data from the Literature Supporting Need for the Project 
Although the ACC/AHA teamed up to create CPGs, HCPs are not adhering to these 
developed CPGs (Goff et al., 2013, Fox et al., 2015; Stone et al., 2013). Physician barriers for 
not adhering to CPGs include: (a) lacking input in regard to the creation of CPGs, (b) a weak 
level of evidence when forming the CPGs, (c) lacking clarity, (d) length of the CPGs, (e) 
ambiguity of the CPGs (Alexander et al., 2016), (f) content disagreement, (g) unaware or lack 
familiarity of the CPGs, (i) inadequate time associated with implementing CPGs, and lacking 
resources (Barth et al., 2016). Healthcare providers who adhere to recommended CPGs have 
noted better patient outcomes (Barth et al., 2016; Hendrix et al., 2014; Jun et al., 2016; McKee 
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et al., 2016). Registered nurses express similar barriers for not adhering CPGs as those 
denoted by physicians, which include: (a) attitudes and perceptions, (b) motivation, cultural 
differences, (c) reluctance, (d) no benefit, (e) knowledge, (f) usability, (g) not easily accessible, 
(h) format and content, (i) conflicting evidence, (j) many without goals, (k) clarity or direction,( l) 
conflicting with physician’s practices, (m) time, (n) workload, (o) equipment, (p) leadership 
support, and (q) the culture of the organization (Jun et al., 2016; McKee et al., 2017).  
Several strategies have been published regarding how to implement CPGs into practice. 
Researchers have noted that the following techniques have been beneficial in improving patient 
CPG adherence: (a) audit and feedback (Ivers et al., 2012), (b) computer-generated reminders 
delivered on paper (Arditi et al., 2017; Garza et al., 2017), (c) paper reminders with highlights 
(Hendrix et al., 2015), (d) EMR prompts (Garza et al., 2017; Hendrix et al., 2015), (e) on screen 
point of care reminders (Shojania et al., 2009), and (f) manual paper reminders (Pantoja et al., 
2014).  
Garza et al. (2017) conducted a quality improvement project that sought to improve 
primary prevention of CVD among adults with T2DM. The researchers created alerts in the EMR 
system that alerted HCPs for adults with and without complicated T2DM who had never had a 
cardiovascular event to follow CPGs. The alert system opened the PCE to calculate a patient’s 
10-year ASCVD risk factor for HCPs to complete if one had not been completed within the last 5 
years. The EMR alert system improved CPG compliance through initiating a statin or an aspirin 
regimen, as well as educating patients about the importance of healthy diet and exercise (Garza 
et al., 2017). The authors noted that alert systems work when the systems are properly utilized, 
stakeholders are involved and agree with changes, and individuals work as team players.  
Data from the Clinical Agency Supporting Need for the Project 
 Upon providing care for patients in an urban Midwest community clinic, the Project 
Leader (PL) noted that at-risk patients were not being treated with proper medications to 
prevent primary CVD. A pilot audit of 100 patient charts showed that 63 patients who attended 
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point of care visits within the past 2 years and who met the criteria recommended by the 
ACC/AHA, AHA/ADA, and the USPSTF were not prescribed a statin or aspirin to prevent to 
prevent primary CVD. Given the information available to the PL, it was unclear if the lack of 
adherence of HCPs to CPG recommendations was due to lack of knowledge about CPGs 
among HCPs, ambiguity about CPGs, the time constraints associated with implementing CPGs, 
or that HCPs were too comfortable their current medical practices. Furthermore, laboratory 
findings revealed that many patients who were 40 to 75 years of age had a LDL-C of 70 mg/dl to 
189 mg/dl, elevated or stage 1 hypertension, T2DM, smoked, and/or were obese, thus 
confirming that screenings were not properly conducted nor were strategies implemented to 
prevent primary CVD. Some patients, ages 40 to 75, did not have a baseline lipid panel ordered, 
which is problematic because lipid panels can alert HCPs to patients who have dyslipidemia, 
are at risk for primary CVD, and require statin initiation. Furthermore, patients who did have a 
lipid panel ordered did not follow up with testing. 
The PL observed that HCPs, at the project site, did not utilize the PCE to evaluate 
patients’ 10-year ASCVD risk factors. This failure to use the PCE is concerning because 
patients need to be initiated on a moderate or high dose statin and/or aspirin, as noted by the 
current CPGs (Fox et al., 2015; Stone et al., 2013). In addition to lacking CPG implementation, 
the PL observed that there was no mechanism in place for reminding HCPs to identify adult 
patients at-risk for primary CVD. While the facility uses an EMR system, there was no reminder 
system in place for HCPs to perform the PCE to evaluate if patients need a statin and/or aspirin 
initiated. After communicating with information technology staff members, the PL found that the 
facility was not able to implement an electronic reminder in the EMR for this medical practice 
because of interference throughout the enter hospital system.  
Finally, the facility began receiving notifications from insurance companies that reminded 
HCPs to initiate statin therapy for T2DM patients. Therefore, the initial focus of this EBP project 
shifted from patients diagnosed with T2DM to all patients at-risk (such as those who have 
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dyslipidemia, HTN, and/or T2DM) for prevention of primary CVD. Broadening the population to 
include patients who had a diagnosis of dyslipidemia and HTN was also warranted based on the 
data collected during the pilot. 
Purpose of the Evidence-Based Practice Project 
The purpose of this EBP project was to alter standard practice among HCPs by 
improving their adherence to CPGs by prescribing a statin and/or aspirin among patients who 
have been diagnosed with dyslipidemia, HTN, and/or T2DM and have a 10-year ASCVD risk 
factor of greater than or equal to 7.5%. Changing practice to conform to CPGs potentially 
prevents primary CVD in these at-risk patients. It is imperative that HCPs take the time to utilize 
the PCE, which is available through the AHA or ACC website or for download to their mobile 
device, to ensure ease of equation access. Through using the PCE, HCPs can estimate 10-year 
ASCVD risk factors among patients, as well as educate adult patients about lifestyle 
modification to assist in preventing primary CVD. 
Compelling Clinical Question 
The compelling clinical question that guides this study is, “What is the best intervention 
to implement for HCPs to adhere to CPGs, so at-risk adult patients will be prescribed a statin 
and/or aspirin in accordance with the ACC/AHA AHA/ADA CPGs and USPSTF 
recommendations?” The decision to adhere to the CPGs must be made by evaluating a 
patient’s modifiable and non-modifiable risk factors, assessing patients estimated 10-year 
ASCVD risk factor (through utilizing the PCE), evaluating patients’ allergies, risk of side effects 
versus benefit of initiating a statin and/or aspirin, and a collaborative agreement among the HCP 
and patient.  
PICOT Question 
The PICOT question that guided this study is, “For healthcare providers in a primary 
care setting, does incorporating a multi-modal approach that involves education, using 
computer-generated paper reminders at point of care, visual cues, and ongoing feedback about 
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prescribing performance improve the initiation of medication therapy for the prevention of 
primary CVD in at-risk adult patients over a 7-week period?” 
Significance of the EBP Project 
It is imperative that HCPs move evidence into practice by implementing strategies that 
remind them to initiate a statin and/or aspirin for at-risk patients. Electronic medical record alerts 
(Garza et al., 2017; Shojania et al., 2009), audits and feedback (Ivers et al., 2012; Li, 2018), 
education (Jeffery et al., 2015), computer-generated paper alerts (Arditi et al., 2017), manual 
paper reminders (Pantoja et al., 2014), highlighting prompts on paper reminders (Hendrix et al., 
2015), and CDSS (Fiks et al., 2015; Rokstad et al., 2013; Zahanova et al., 2017) are a few 
strategies that can be implemented to ensure CPG compliance by HCPs. Healthcare providers 
who utilize strategies to implement CPGs have noted improved patient outcomes (Fox et al., 
2015; Goff et al., 2013; Stone et al., 2013).  
 Through determining the best evidence-based practices, this doctoral EBP project had 
the potential to improve HCP adherence to the guidelines set forth by the ACC/AHA (2013, 
2018), the AHA/ADA (2015), and the USPSTF (2016). The aforementioned guidelines 
recommend that patients who are 40 to 75 years old and have an estimated 10-year ASCVD 
risk factor greater than or equal to 7.5, an LDL-C of 70-189 mg/dl, a SBP greater than or equal 
to 130, and a DBP greater than or equal to 80 should be started on a statin and/or aspirin 
regimen (Fox et al., 2015; Stone et al., 2013; USPSTF, 2016; Whelton et al., 2018). Every 5 
years, a patient’s ASCVD should be calculated using the PCE, which is available through the 
ACC and AHA websites, as well as available for download using one’s mobile device (Goff et 
al., 2013; Stone et al., 2013). The prevention of primary CVD among at-risk adult patients aligns 
with the goals expressed by Healthy People 2020 (2014). Additionally, DNP prepared nurses 
are in a unique position to implement strategies to assist HCPs stay abreast of CPGs. 
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CHAPTER 2 
 
THEORETICAL FRAMEWORK, EBP MODEL, AND REVIEW OF LITERATURE 
 Evidence-based practice, theory, and EBP models are fundamental aspects of to the 
practice of DNP prepared nurses because these aspects work together to guide practice. 
Evidence-based practice is essential for changing practice to obtain the best possible patient 
outcomes. The PL believes that through implementing this DNP project, a culture of change can 
occur from current practice by HCPs to a culture in which HCPs adhere to prescribing or statins 
and/or aspirin so that patient outcomes can improve. The incorporation of CPGs can assist in 
preventing primary cardiovascular disease among adult patients who have identified risk factors 
(i.e., dyslipidemia, HTN, and/or T2DM) (Fox et al., 2015; Stone et al., 2013).  
The PICOT question that guided this EBP project reads, “For healthcare providers in a 
primary care setting, does incorporating a multi-modal approach that involves education, using 
computer-generated paper reminders at point of care, visual cues, and ongoing feedback about 
prescribing performance improve the initiation of medication therapy for the prevention of 
primary CVD in at-risk adult patients in a 7-week period?” 
Theoretical Framework 
 There are various theoretical frameworks that nurses can use to guide evidence-base 
projects. For example, nurses are introduced to nursing theory in undergraduate nursing 
baccalaureate programs. Nursing schools often utilize a theoretical framework to guide nursing 
curriculum. Nurses can focus the care that they provide to patients using a theoretical 
framework. Oftentimes, DNP prepared nurses are well versed about theories and use them to 
guide EBP projects. The selected theory must be the best choice for the population, 
environment of focus, and goal of the EBP project. 
Overview of Theoretical Framework 
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 After researching various change models, which are well respected in the field of 
nursing, the PL realized that Kotter’s 8-step change model (Kotter, 1995, 1996, 2012) best 
aligned with this EBP project’s purpose. Kotter (1995) initially wrote about his change model in 
Harvard Business Review.  Although, the 8-step change model is often applied in organizations, 
this model can work well when making changes to HCPs daily practice. For example, Mork, 
Krup, Hankwitz, and Malec (2017) utilized Kotter’s change theory to create change efforts 
regarding handoff communication among nurses in an intensive care unit. Small et al. (2016) 
performed the same quality improvement project as Mork et al (2017), on a surgical orthopedic 
trauma unit, where 96% of patients and 86% of nurses were satisfied with the changes made 
regarding handoff communication. Mork et al. stated that with stakeholders, directors, and 
managers being onboard with the changes to handoff communication, the change was 
successful. Kotter’s change framework has been utilized to implement change in a football for 
health program (Langton, Khan, & Lusina, 2010), transforming library services (Wheeler & 
Holmer, 2017), and for integrated care communities (Bradbury, 2014). The 8-step plan is easy 
to follow and adaptable to any environment (Mork et al., 2017). 
Kotter’s (1996, 2012) 8-step change model includes three phases and 8-steps. Phase 
one is the defrost phase which consist of steps 1-4 which is when the transformation process is 
occurring, phase two which is the introduction and implementation of the change which includes 
steps 5-7, and phase 3 includes steps 8 which is anchoring the change by making the change 
permanent. Kotter explained that each step of the model must be completed for successful 
change to occur. Kotter (1996, 2012) continues to explain that prior steps must be reinforced 
when issues arise while moving to the next step. The steps for the 8-step change model include:   
1) establishing a sense of urgency,  
2) creating the guiding coalition,  
3) developing a vision and strategy,  
4) communicating the change vision,  
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5) empowering broad-based action, 
 6) generating short term wins,  
7) consolidating gains and producing more change, and  
8) anchoring new approaches in the culture (Kotter, 1996, p. 21). 
The PL selected Kotter’s model of change because organizational change needed to occur in 
the selected project location. The PL recognized the critical nature of organizational change, 
specifically among HCPs who were not following CPGs. The CPG process implemented 
involved prescribing a statin and/or aspirin in patients who had a diagnosis of dyslipidemia, 
HTN, and/or T2DM, as well as a 10-year ASCVD risk factor of greater than or equal to 7.5%. 
The goal of this project was to implement strategies to facilitate HCPs prescribing a statin and/or 
aspirin to prevent primary CVD among at-risk adult patients. 
Application of Kotter’s Framework to EBP Project 
Establishing a sense of urgency entails identifying problems within the organization 
(Kotter, 1996, 2012). Preventing primary CVD in T2DM patients was established as a priority for 
patients who were being provided care in the urban walk-in clinic in which this project was 
conducted. A pilot chart audit was performed to establish feasibility for the project. Based upon 
the results of the pilot chart audit, it was determined that HCPs were not prescribing statins 
and/or aspirin to at-risk patients who had a 10-year ASCVD score great than or equal to 7.5%. 
Therefore, the focus of this project was broadened to preventing primary CVD in at-risk adults 
including those who had a diagnosis of dyslipidemia, HTN, and T2DM.  
The second step of Kotter’s change model involves creating the guiding coalition, which 
entails determining individuals who can lead the coalition for change, as well as encouraging 
teamwork among group members (Kotter, 1996, 2012). The project leader encouraged 
teamwork among the medical assistants and the office manager, thus enhancing the EBP 
project’s likelihood of success. The project leader asked the medical assistants to lead the 
coalition and to ensure that the PCE was being completed and printed. Furthermore, the office 
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manager was asked to assure the paper reminders were placed in the examination rooms so 
the HCPs would refer to them when prescribing a statin and/or aspirin for at-risk patients.   
The third step in Kotter’s change model (Kotter, 1996, 2012) involves developing a vision 
and strategy. For this project, the third step of Kotter’s model was utilized by ensuring that key 
stakeholders were educated about strategies that could enhance CPG compliance about 
prescribing a statin and/or aspirin in patients who had a diagnosis of dyslipidemia, HTN, and/or 
T2DM and had a 10-year ASCVD risk factor of greater than or equal to 7.5%. During the first 
week that this project began, the PL was in the office each day. The PL educated the office 
manager and medical assistants regarding how to properly perform the PCE to calculate a 
patient’s 10-year ASCVD risk factor. 
Step four in Kotter’s change model involves communicating the change vision to key 
organizational stakeholders. Specifically, this process involved educating and communicating 
the project’s vision and strategies to all participants, as well as reiterating the vision to 
organizational stakeholders (Kotter, 1996, 2012). A PowerPoint presentation was presented to 
HCPs, medical assistants, and the office manager regarding the fact that HCPs were not 
prescribing statins or aspirin to prevent primary CVD in at-risk patients. The PL provided an 
educational session about the national statistics for CVD mortality. Additionally, pilot chart audit 
data were provided to all HCPs. Education about the 2013, 2015, and 2018 CPGs were 
discussed and details regarding the 10-year ASCVD risk calculator were provided, thereby 
ensuring comprehension among participants. Additional education was provided to the medical 
assistants and the office manager regarding where the PCE was located. When providing 
information about the PCE, a see one, do one, teach one approach was utilized. To remind 
HCPs about CPGs, a visual cue (flowsheet) (Appendix B) was placed in each examination 
room. 
The fifth step begins phase two in Kotter’s change model which involves empowering 
broad-based action. This step ensures that obstacles are removed, specifically those that will 
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hinder change from occurring (Kotter, 1996, 2012). To carry out this step, education about 
CPGs was provided to HCPs, medical assistants, and the office manager. The HCPs were 
informed that they would receive each patient’s ASCVD risk factor percentage. Based on the 
ASCVD percentage and a patient’s diagnosis of dyslipidemia, HTN, and/or T2DM, HCPs were 
asked to recommend that patients start on a moderate or high dose statin, an aspirin, or both 
treatment regimens. The PL provided step-by-step instructions to the medical assistants and the 
office manager regarding the online location of the AHAs and ACCs PCE.  Furthermore, the PL 
demonstrated to the medical assistants and office manager what information belonged in each 
category of the PCE to calculate at-risk patients’ 10-year ASCVD risk factor and showed 
individuals how calculation results would appear. These results were printed out and the 
patient’s identification number was written in the top right-hand corner, thereby revealing whose 
ASCVD risk factor percentage was obtained without providing any identifying demographics. To 
ensure anonymity, no patient information was saved on the computer nor kept on the calculator. 
The computer-generated reminder was printed out then placed in the examination room with the 
patient. The PL showed the medical assistants and office manager where to place the printed 
calculation form so HCPs would notice the printed 10-year ASCVD risk factor calculation. The 
form provided details to HCPs regarding if a patient needed or did not need the statin or aspirin 
intervention. The PL asked the medical assistants and office manager to return the printed PCE 
calculation to the front desk and place it in a manila folder.   
Step six of Kotter’s change model involves generating short-term wins. These short-term 
wins consist of visibility, unambiguousness, and clarity and are related to the change effort 
(Kotter, 1996, 2012). Kotter (1996, 2012) stated that the roles of short-term wins are to: (a) 
provide evidence that sacrifices are worth it, (b) reward change agents with a pat on the back, 
(c) help fine-tune vision and strategies, (d) undermine critics and self-serving resisters, (e) keep 
bosses on board, and (f) build momentum. To accomplish short-term wins, the PL conducted 
weekly audits of five charts over the 7-weeks during which this project was conducted. Monthly 
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lunches were also provided, by the PL, to the HCPs during the times project members met to 
discuss the project. During these meetings, the PL and project participants discussed 
adherence or nonadherence to CPGs. Additionally, the PL provided feedback, as needed, to 
ensure project success. However, the medical assistants and office manager received a positive 
verbal gesture along with monthly lunches for performing the PCE calculations and providing 
the printed reminders for the HCPs to locate and intervene on at-risk patients. 
Step seven in Kotter’s (1996, 2012) change model involves consolidating gains and 
producing more changes. To ensure that changes are made, the change process must 
continue, and a sense of urgency and momentum must be established. It is important to note 
when short-term wins are accomplished (Kotter, 1996, 2012). For this project, the PL 
acknowledged and displayed appreciation for the progress being made by the medical 
assistants and office manager, specifically in terms of thanking these individuals for supplying 
HCPs with patients’ 10-year ASCVD risk factor calculations. Furthermore, the PL provided 
positive feedback to HCPs as they continued to change their daily practice by adhering to CPGs 
by prescribing a statin and/or aspirin in patients who have a diagnosis of dyslipidemia, HTN, 
and/or T2DM and a 10-year ASCVD risk factor greater than or equal to 7.5%. Additionally, the 
PL informed all stakeholders of the goal of this EBP project, which involved 100% of patients 
who were diagnosed with dyslipidemia, HTN, and/or T2DM and demonstrated a 10-year 
ASCVD risk calculation of greater than or equal to 7.5% being started on a statin and/or an 
aspirin regimen. 
The final step is phase three of Kotter’s change model involves anchoring new 
approaches in the culture by making change permanent within an organizational culture (Kotter, 
1996, 2012). The success of this step depends on results, requires a great deal of conversation, 
may result in turnover, and involves decisions regarding succession planning. Organizational 
change can be a slow and tedious process, which is often difficult since individuals are 
accustomed to their normal routines. To ensure that the change was successfully implemented, 
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the project leader assisted with the PCE, as necessary; however, this assistance was not 
habitual. Feedback regarding the results provided to the HCPs during the pre-intervention, 
implementation, and post-intervention phases of this project.  
Strengths and Limitations of Theoretical Framework for EBP Project 
Several organizations have utilized Kotter’s 8-step change model (Bradbury, 2014; 
Langton et al., 2010; Mork et al., 2017; Small et al., 2016; Wheeler & Holmer, 2017) since its 
inception. In 1995, the model was updated and published. Kotter’s 8-step change model is 
highly regarded by organizational development practitioners, scholars, and change agents. The 
8-step change model has been used in businesses, as well as within healthcare organizations, 
thus reinforcing the model’s applicability regardless of industry/setting.   
One of the limitations of this model is that all eight steps had to be completed to ensure 
a successful change effort. Steps can be reinforced as one moves forward to other steps; 
however, steps could not be skipped, overlooked, or rushed (Kotter, 1996, 2012). This approach 
is not always compatible with the culture of the United States because rapid changes are 
preferred. Furthermore, the culture was not open to many change initiatives, thus adding to the 
stressors of deviating from the status quo. This model was too difficult to use given the short 
timeframe of this study. Although the PL believed that this model was best to ensure that 
organizational change occurred, it proved to be challenging in the clinical setting.  
Evidence-based Practice Model 
 Evidence-based practice models are used to guide the implementation of an EBP 
project. Doctor on nursing practice prepared nurses are educated about several types of EBP 
models; therefore, these individuals can choose the best model for projects. Each model is 
different and should be carefully assessed and evaluated prior to model implementation. 
Overview of EBP Model 
 The project leader chose to use the promoting action on research implementation in 
health services framework (PARiHS) as the EBP model for this project. The PARiHS framework 
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includes three elements. Each of the elements has sub-elements. Kitson, Harvey, & 
McCormack (1998) proposed that implementing research into practice is a function (f) and that 
evidence (E), context (C), and facilitation (F) should be considered simultaneously. The formula 
created for the framework to ensure successful implementation is (SI) = f(E, C, F) (Kitson et al., 
1998). All elements must be given equal time and energy, because each element is equally 
important when implementing evidence into practice. 
Evidence can be obtained from various sources and is advantageous in several settings. 
To ensure the quality of evidence, ratings are provided. An example of high-level evidence is 
the use of randomized control trials (RCT) (Kitson et al., 1998). An example of low-level 
evidence is the use of descriptive opinion statements (Kitson et al., 1998). Regardless of the 
level of evidence, if the HCP and the patient agree to the evidence provided, that evidence will 
guide the changes implemented. 
 The context, as represented in the formula above, is related to the setting where the 
implementation of the evidence will occur (Kitson et al., 1998). The context plays a major role in 
the successful implementation of a change effort. The sub-elements to help with the context are 
culture, leadership, and evaluation (Kitson et al., 1998; Melnyk & Fineout-Overholt, 2015). 
 Facilitation consist of the individuals who support and encourage one another throughout 
the implementation process (Kitson et al., 1998). Change is not an easy process and individuals 
are often hesitant of change efforts. Thus, a team effort is needed to support, encourage, and 
provide understanding regarding the desired outcomes associated with the change being 
implemented. Kitson et al. (1998) noted that open dialogues about roles, being open-minded, 
and changing one’s thought process can facilitate a change effort. 
Application of EBP Model to EBP Project 
 For this EBP project, the PL applied the PARiHS framework by obtaining high-level 
evidence from peer-reviewed literature to support the implementation of CPGs into practice by 
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HCPs. The evidence used in this project was appraised and the quality was graded. Only high 
and good quality evidence was used in this project.  
The context for this EBP project was an urban outpatient walk-in clinic. When this project 
began, the PL realized that CPGs were not followed by the HCPs. Therefore, the PL provided 
education to all individuals who were involved in this EBP project, thus ensuring understanding 
of the requirements, the purpose of the project, etc.  Furthermore, when questions arose, the PL 
answered questions accordingly. To ensure successful project implementation, the PL 
emphasized the importance of teamwork to improve patient outcomes.   
The PL supported the medical assistants throughout the facilitation of this EBP project. 
The PL assured the medical assistants were completing the PCEs for at-risk patients and the 
computer-generated reminders were placed in examination rooms. The computer-generated 
reminders alerted HCPs initiate a statin and/or aspirin for the prevention of primary CVD at point 
of care visits. The project leader was available to HCPs and medical assistants for questions 
regarding the PCE calculation, the 10-year ASCVD risk factor for primary CVD, and which 
intensity of medication should be prescribed based on the patient’s risk factor. 
Strengths and Limitations of EBP Model for EBP Project 
 The PARiHS framework was selected because its focus involves moving evidence to 
practice. Kitson et al. (1998), the creators of PARiHS, provided three core values to help guide 
the implementation process which are evidence, context, and facilitation. The PARiHS 
framework has been refined, since inception, and has face validity, content validity, and 
construct validity (Kitson et al., 1998; Rycroft-Malone et al., 2004). While there are various 
strengths associated with PARiHS, limitations also must be explored. As previously noted, 
HCPs are accustomed to their normal practice, therefore utilizing the PARiHS framework 
changes the workflow for HCPs. Before this project was implemented, the PL realized that 
HCPs may experience barriers (i.e., not agreeing with the intervention/approach) when using 
CPGs to prevent primary CVD in at-risk patients.  
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Literature Search 
Evidence-based practice is an essential component of DNP preparation and to the 
discipline of nursing. Doctor of nursing prepared nurses are expected to keep abreast about 
new evidence, thereby ensuring that the highest quality of care is provided to patients. As 
primary care providers, DNPs must also be prepared to implement EBP projects that can assist 
in the improvement of patient care outcomes. To ensure that the best evidence is utilized, DNPs 
need to conduct thorough literature reviews. Through utilizing timely, high-quality, and highly 
cited sources, DNPs can ensure that they are utilizing highly regarded EBPs. Conducting a 
saturated search of literature is a vital task for DNPs.  
Sources Examined for Relevant Evidence 
For this project, the PL performed a saturated search to find the most relevant evidence 
for preventing primary CVD in at-risk patients. The focus of the literature search was to locate 
evidence that discussed strategies to alert, prompt, or remind HCPs to comply with CPGs. The 
PL gathered the highest level and best quality of evidence, using several databases, to support 
this EBP project. The PL utilized various search strategies and databases to ensure that all 
literature was explored. The Cumulative Index to Nursing and Allied Health Literature (CINAHL), 
Cochrane, Joanna Briggs Institute (JBI), Medline, and the Nursing and Allied Health were 
thoroughly explored. Duplicate pieces of evidence were eliminated. The Preferred Reporting 
Items for Systematic Reviews and Meta-analyses (PRISMA) process is summarized in Figure 
2.1.  
The inclusion criteria used by the PL consisted of evidence that discussed alert, 
reminder, prompt, or decision support systems. General practitioners, primary care providers, 
and ambulatory/outpatient/hospital settings were also included. Evidence included in this project 
involved studies that have been published within the past 5 years (2013-2018). An exception of 
this timeline was made for two pieces of evidence, which were collected during the citation 
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chase. Evidence was excluded that solely focused on patient reminders, patient adherence, and 
bedside nursing reminders and adherence.
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Figure 2.1. PRISMA flow chart of Literature Review 
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The CINAHL database search yielded 76 pieces of evidence. The initial search of 
CINAHL database involved the following search keywords: decision support system, clinical, 
and technique. This initial search yielded 1,266 pieces of evidence. The next CINAHL heading 
reminder systems with the Boolean operator OR between each which yielded 1,501 pieces of 
evidence. The next line search consisted of the following keywords: provider, practitioner, 
physician, healthcare provider, and doctor. These keywords yielded 352 pieces of evidence. 
With 352 pieces of evidence, additional Boolean operators (AND and OR) were utilized. 
Furthermore, quotations around two or more words and phrases, as well as an asterisk for  
truncation led to the discovery of more evidence. The PL added a third line of keywords, which 
resulted in a more succinct search. The keywords used during the third line of keywords search 
included: guideline, protocol, practice guideline, and clinical practice guideline. This final step in 
the search process resulted in the discovery of 76 pieces of evidence. The PL limited the 
CINAHL database search to articles that were published from 2013 to 2018, were in 
scholarly/peer-reviewed journals, and were written in the English language.  
A search of the Cochrane database yielded 71 results. The keyword that was used in the 
initial search was: reminder system. The second search included the keyword decision support 
system and included the Boolean operator OR between both keywords. This search resulted in 
73 articles. During the third search, other keywords utilized included: provider, practitioner, 
physician, healthcare provider, and healthcare professional. During this step in the process, the 
Boolean operator AND was added to the beginning of the search and the Boolean operator OR 
was placed between each keyword. Quotations were placed around keywords with two or more-
words phrases. The final addition of the keywords yielded 71 results. The limiters used when 
searching the Cochrane database included articles that were published from 2013 to 2018 and 
Cochrane Reviews. 
The Medline database was searched, and 80 pieces of evidence were located.  The 
initial medical subject headings (MeSH) searched used the term “reminder systems,” which 
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yielded 680 pieces of evidence. The second MeSH heading used included the term “decision 
support systems.” When using the term “decision support systems,” the PL added a Boolean 
operator OR between each MeSH heading, thereby yielding 6,636 pieces of evidence. 
Keywords added to this search included: doctor, nurse, clinician, physician, practitioner, 
healthcare professional, and healthcare provider, thus yielding 1,726 results. All keywords had 
the Boolean operator OR between each keyword, the Boolean operator AND between each line, 
and an asterisk was added for truncation to yield the most results. The PL then added another 
line, which began with the Boolean operator AND. Furthermore, other keywords used included: 
guideline, protocol, practice guideline, and clinical practice guideline. This step yielded 406 
pieces of evidence. A final line of key phrases was added to this search and began with the 
Boolean operator AND. In the final line, keywords included: primary care, family practice, and 
physician office, thereby yielding 80 pieces of evidence. All keywords had the Boolean operator 
OR between each and each line began with the Boolean operator AND. Phrases with two or 
more-words phrases were placed in quotation marks, so the database did not separate the 
words during the search. The limiters used when searching the Medline database included 
articles that were published from 2013 to 2018 and articles written in the English language.  
The Nursing and Allied Health database was also searched and yielded 120 results 
during the final search. The keyword utilized with MeSH headings included “reminder systems,” 
thereby yielding 18 pieces of evidence. Decision support systems MeSH headings were added 
to the search and resulted in 155 pieces of evidence. All MeSH headings had the Boolean 
operator OR between each heading. The PL added another line with the Boolean operators 
AND at the beginning of each line, as well as OR between each keyword. During the third 
search, the PL used the keywords: clinical provider, practitioner, physician, healthcare provider, 
and doctor. This step in the search yielded 120 pieces of evidence. Quotations were placed 
around keywords with two or more phrases and an asterisk was placed for truncation. The 
limiters utilized when searching the Nursing and Allied Health database included articles that 
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were peer reviewed, published in scholarly journals from 2013-2018, and were written in the 
English language. It is important to note that the database only yielded evidence from 2013-
2014. 
The JBI database was searched and yielded 30 pieces of evidence. The keyword used 
during the initial search included the word reminder system, which was input with quotations, 
thereby yielding 16 results. Of the 16 results yielded, only one of the results was relevant to the 
study. The next search included the keyword decision support system and used the Boolean 
operator AND between both keywords (i.e., reminder system AND decision support system). 
This search yielded 30 results. From the 30 results gathered, only 3 pieces of evidence were 
relevant to the study. A third search line was included, but the PL did not consider the search as 
a relevant step, specifically since this search removed relevant evidence. The keywords used in 
the final step included: provider, practitioner, physician, healthcare provider, and doctor. 
Boolean operators AND and OR were utilized. Furthermore, quotations were used around two 
or more-word phrases. This final search yielded 22 results. Of the 22 results, only 2 pieces of 
evidence were relevant to this study. The limiter used when searching the JBI database was 
articles published from 2013-2018.  
The PL also citation chased three pieces of evidence. Citation chasing consist of 
locating a piece of evidence which was cited in another piece of evidence that was not yielded 
in the search criteria but is important for a paper or project. Of the three pieces of evidence 
located, two of the articles were outside of the publication date limiters. Despite the timeframe 
used, the citations found were relevant and high-level pieces of evidence. Therefore, these two 
citations were included to support this EBP project. The database search results for this project 
are detailed in Table 2.1. 
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Table 2.1  
Database Search Results 
Database Evidence 
Yielded 
Duplicates Reviewed Accepted 
CINAHL 76 7 20 3 
Cochrane 67 0 10 3 
Joanna Briggs Institute 30 0 3 1 
Medline 80 5 11 1 
Nursing and Allied Health 120 1 6 0 
Citation chased 3 0 3 3 
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Level of Evidence 
The PL utilized the Johns Hopkins Nursing Evidence-Based Practice (JHNEBP) (Dang & 
Dearholt, 2018) as the selected appraisal tool. The JHNEBP tool is used to rate the level of 
evidence selected. The level of evidence ratings, for each piece of evidence used in this project, 
is presented in Table 2.2. 
Appraisal of Relevant Evidence  
An appraisal of each of the final 10 articles (Appendix A) was conducted utilizing the 
JHNEBP appraisal tool. The JHNEBP rates the level of evidence and can be utilized as an 
appraisal tool to analyzes the design, quality, consistency, and applicability of the evidence 
(Dang & Dearbolt, 2018). The PL selected this tool because of its ease of use, detailed 
description, and the rating scale utilized to assess the quality of evidence presented. The 
JHNEBP rating hierarchy has five levels, levels I-III is considered researched evidence, while 
levels IV-V is non-researched evidence. The rating hierarchy for the level of research evidence 
is found in Table 2.2 and in Appendix A. 
The JHNEBP rating tool can be used to appraised evidence. The appraisal tool allows 
users to rate the quality of evidence. Quantitative and qualitative research can be appraised 
using the JHNEBP appraisal tool. Quality of evidence is given a grade A, B, or C which is 
consistent with a high to low rating.  
Evidence given a quality grade level of high (A) has “consistent, generalizable results; 
sufficient sample size for study design; adequate control definitive conclusions; consistent 
recommendations based on comprehensive literature review that includes thorough reference to 
scientific evidence” (Dang & Dearbolt, 2018, p. 131). For this study, there were seven quality A 
graded pieces of evidence used. Studies that were given a grade A include: Arditi et al. (2017), 
Fiks et al. (2013), Flodgren et al. (2016), Hendrix et al. (2015), Ivers et al. (2012), and Li (2018). 
Evidence given a quality grade level of good (B) included “reasonably consistent results; 
sufficient sample size for the study design; some control; fairly definitive conclusions; 
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reasonably consistent recommendations based on fairly comprehensive literature review that 
includes some reference to scientific evidence” (Dang & Dearbolt, 2018, p. 131). For this 
project, there were three quality B graded pieces of evidence: Regan, (2017), Rokstad et al. 
(2013), Shojania et al. (2009), and Zahanova et al. (2017). 
Evidence given a quality grade level of low or majorly flawed (C) demonstrates “little 
evidence with inconsistent results; insufficient sample size for the study design; conclusions 
cannot be drawn” (Dang & Dearbolt, 2018, p. 131). For this project, there were no quality level C 
grade evidence used. The quality of the evidence is discussed in the detailed level of evidence 
appraisal for each piece of evidence utilized for this project. The quality rating for this research 
evidence is found in Table 2.2 and Appendix A. 
Level-I evidence. According to Dang and Dearbolt (2018) level-l evidence is defined as 
“an experimental study randomized control trial (RCT), explanatory mixed methods with only 
level I quantitative study or systematic review of RCTs, with or without meta-analysis” (p. 130). 
For this project, there were four sources of evidence that were rated as level-l evidence:  
Flodgren et al. (2016), Hendrix et al., (2015), Ivers et al. (2012), and Li (2018). 
Flodgren et al. (2016) performed a systematic review evaluating if tools developed and 
disseminated by individuals who produce guidelines are effective in ensuring guideline 
implementation. For the systematic review, the authors utilized four cluster-RCTs, which were 
conducted in various locations. The studies included in the systematic review of literature 
focused on HCPs adherence to guideline. One of the studies used an educational workshop as 
the intervention. Three of the other studies utilized forms, reminders, paper-based educational 
material, or a combination of all tools to ensure compliance. The sample size included four 
RCTs, which all involved HCPs, health system managers, and policymakers. 
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Table 2.2 
Rating Hierarchy for Level of Research Evidence using the JHNEBP Appraisal Tool 
Author(s) Grade of  
Evidence 
Level of  
Evidence 
Database 
Arditi, Rege-Walther, Durieux, and 
Burnand (2017) 
A II Cochrane Database of 
Systematic Reviews. 
Fiks, Zhang, Localio, Khan, 
Grundmeier, Karavite, … Forrest (2013) 
A I CINAHL 
Flodgren, Hall, Goulding, Eccles, 
Grimshaw, Leng, and Shepperd (2016) 
A I Cochrane Database of 
Systematic Reviews 
 
Hendrix, Downs, and Carroll (2015)  A I  Citation chase 
Ivers, Jamtvedt, Flottorp, Young, 
Odgaard-Jensen, French, … Oxman 
(2012) 
A I Cochrane Database of 
Systematic Reviews 
Citation chased 
Li (2018) A I Joanna Briggs Institute 
Regan (2017) B III CINAHL and Medline 
Rokstad, Rokstad, Holmen, Lehmann, 
and Assmus (2013) 
B II CINAHL 
Shojania, Jennings, Mayhew, Ramsay, 
Eccles, and Grimshaw (2009) 
A II Cochrane Database of 
Systematic Reviews 
Citation chased 
Zahanova, Tsouka, Palmert, and 
Mahmud (2017) 
B II CINAHL 
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For each of these four reviewed RCTs, trainees and medical students were excluded. 
Interventions by the World Health Organization (WHO), the National Institute for Health and 
Care Excellence (NIHCE), and the Scottish Intercollegiate Guidelines Network (SIGN) were 
included because these interventions involved the creation of CPGs to improve guideline 
implementation (Flodgren et al., 2016). Interventions such as learning modules, educational 
outreach visits, communication tools, and tailored formatting were created by CPG producers 
(i.e., WHO, NIHCE, and SIGN). The creators suggested assessing the feasibility and impact of 
creating templates that automatically generate patient’s data. The systematic review of literature 
noted that CPG acceptance, by HCPs, may be better received and implemented when a CDSS 
is utilized. The interventions were categorized according to the following classifications: 
tailoring, education, targeting the patient, targeting the organization of care, and mass media 
interventions. No theory guided any of the studies utilized in this systematic review. The authors 
concluded that adherence to CPGs by HCPs improves when tools, developed by creators of 
CPGs, are implemented. The level of evidence for this systematic review was rated a level one 
and the quality was rated high, which denotes a grade A rating. 
Hendrix et al. (2015) performed a (RCT) that consisted of four pediatric offices. The 
researchers evaluated if highlighted prompts caused physicians to respond quicker than when 
using non-highlighted prompts. Two offices were included in the intervention group which 
received CDSS generated prompts highlighted in yellow. The other two offices were included in 
the control group and did not receive prompts highlighted in yellow. The prompts were 
randomized and were then delivered to the medical offices. The researchers also added 
highlighted high-priority prompts. The high-priority prompts were not randomized because of 
their importance. A total of 2237 prompts were randomized and delivered to physicians. The 
results of this study did not indicate any statistically significant difference between 
responsiveness to highlighted prompts versus non-highlighted prompts (odds ratio 1.056; 95% 
confidence interval 0.56-1.167; p = .259, NS; X2 = 0.3; p = .58, NS). Furthermore, the 
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researchers did not find improvement between physicians responding to highlighted high priority 
prompts as compared to the prior years when non-highlighted prompts were utilized. Chi-square 
and binary regression were utilized to analyze the RCT results. Bonferroni correction was 
utilized to establish a cutoff for statistical significance. A post hoc power analysis of 80% was 
obtained to detect the absolute difference in response rate of 5% for the overall study (Hendrix 
et al., 2015). The researchers utilized the signal detection theory to discuss possible reasons 
why physicians did not respond to highlight prompts. The researchers initially hypothesized that 
highlighted prompts would result in improved responsiveness by the physicians. Intrinsic and 
extrinsic factors such as lack of motivation and operational conditioning regarding responding to 
reminder prompts are two possible reasons for the minimal response rates from physicians 
when responding to the highlighted prompts. The researchers postulated that paper prompts 
were a study limitation. The researchers suggested structured feedback about ignored prompts, 
highlighting prompts on a computer screen, and hard stops in EMR systems for future 
interventions to improve physician’s responsiveness to highlighted prompts. This RCT study 
was given a level-l evidence rating and a quality rating grade of A by the project leader. 
Ivers et al. (2012) performed a systematic review to assess the effectiveness of audit 
and feedback regarding HCPs daily practice and patient outcomes. The reviewers had three 
objectives that were addressed in their study (Ivers et al., 2012, p. 6): 
1) Is audit and feedback effective for improving health provider performance and 
healthcare outcomes? 
2) What are the key factors that explain variations in the effectiveness of audit and 
feedback? 
3) How does the effectiveness of audit and feedback compare to other 
interventions?  
         This systematic review included 140 RCTs that focused on audit and feedback. Audit was 
defined as evaluating any individual’s professional practice, while feedback was defined as a 
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process of communicating process measures to the professional. The samples included health 
care professionals. Studies that focused on facilitation or reminders systems were excluded 
from this systematic review. The results of this systematic review showed that healthcare 
professionals who have low baseline compliance are more inclined to respond to audit and 
feedback. Audit and feedback, along with other interventions (i.e., such as reminders or 
educational meetings), have limitations. The acceptance of information provided in audit and 
feedback depends on the individual’s mindset and motivation level. For this systematic review, 
the reviews focused on individual behavioral change theories. Ivers et al. (2012) concluded that 
professional practices will notice small but important improvements when audits and feedback 
are used as intervention methods. When audit and feedback were the core intervention, a 4.3% 
increase in compliance occurred. Compliance rates improved when using audit and feedback, 
especially when these forms of feedback occurred monthly and involved individuals who have 
authority, seniority, and/or were able to give a verbal or written warning. The researchers 
postulate that with the proper context and design, audit and feedback will improve healthcare 
professional’s practice, thereby improving patient care outcomes. The PL rated this systematic 
review with a level-I score and an A quality rating. 
Li (2018) performed a systematic review of RCTs studies to evaluate if implementing 
audit and feedback, as a strategy, would assist in fostering HCPs practice changes. The author 
evaluated four pieces of evidence. Between the four RCTs utilized, 190 studies were evaluated. 
Each study contained a minimum of one piece of evidence, which focused on audit and 
feedback as a strategy. Li (2018) concluded that audit and feedback alone, as well as in unison 
with other strategies, can improve HCPs practice and patient outcomes. Change agents must 
consider the characteristics of HCPs behaviors and the context in which these strategies are 
applied. This systematic review included all RCTs; therefore, the PL rate the level of evidence a 
level I. High quality, consistent, and generalizable results were provided, thereby resulting in a 
grade A for this systematic review. 
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Level-II evidence. Level-II evidence is defined by Dang and Dearholt (2018) as “a 
quasi-experimental study, explanatory mixed methods with only level II quantitative study, or 
systematic review of a combination of RCTs and quasi-experimental studies, or quasi-
experimental studies only, with or without meta-analysis” (p. 130). For this EBP project, there 
were four sources of level-II evidence used:  Shojania et al. (2009), Arditi et al. (2017), 
Zahanova et al. (2017), and Rokstad et al. (2013). 
Shojania et al. (2009) performed a systematic review to assess the effectiveness of 
computer reminders, during point of care visits, that are delivered on screen to HCPs. The three 
objectives for this systematic review (Shojania et al., 2009, p. 3) included: 
1) Do on-screen computer reminders effectively improve processes or outcomes of 
care? 
2) Do any readily identifiable elements of on-screen reminders influence their 
effectiveness? 
3) Do any readily identifiable elements of the targeted activity influence the 
effectiveness of on-screen reminders? 
The researchers included 28 RCTs and quasi-RCTs. Several databases were utilized by the 
reviewers to obtain relevant studies related to their research topic. The inclusion criteria used for 
this systematic review required that 50% of the participants were physicians or physician 
trainees. The reviewers excluded studies that included nurses, dentists, pharmacists, or other 
health professionals as the research’s primary focus. Adherence to computer reminders 
improved by 4.2% when used as an intervention. However, computer reminders during point of 
care visits, improved HCPs behavior modestly. Study interventions that targeted inpatient 
settings showed an improvement of 8.7% when compared to 3% improvement in outpatient 
settings (p = 0.34). Shojania et al. (2009) denoted the following systematic review limitations, 
which included heterogeneity, variable degree of reporting (such as description of key 
intervention features and the systems which they were delivered), and the authors median 
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effects of focus. Additionally, the authors suggested focusing on quality problems or the 
reminder system design as improvements for future studies/projects. No theoretical framework 
guided this systematic review. The PL rated this systematic review as a level-II, using the level 
of evidence scale, and gave this review an A quality rating. 
 Arditi et al. (2017) performed a systematic review of literature to evaluate if professional 
practice and patient outcomes are affected by computer-generated reminders, which are 
delivered on paper. This systematic review covered (Arditi et al., 2017, p. 7): 
1) Manual paper reminders 
2) Computer-generated paper reminders delivered on paper  
3) On-screen reminders  
The reviewers performed a thorough search of several databases to retrieve the most relevant 
evidence for this review. Thirty-five studies were included in this study, which consisted of RCTs 
and non-RCTs. An outpatient setting was used in all pieces of evidence, except two. The 
inclusion criteria were patients, HCPs, practice, and hospitals. The review compared HCPs 
normal practice, using no reminders, to computer reminders that were delivered on paper. Using 
computer reminders, delivered on paper, as a multifactorial intervention and/or alone, slightly 
improved care by 6.8%. In a single intervention, computer-generated reminders, which were 
delivered on paper to HCPs, improved quality of care by 11%. Adding reminders as an 
intervention to another intervention improved the quality of care by 4.0%. The reviewers 
concluded that computer-generated reminders, which are delivered on paper, slightly improves 
the quality of care received with moderate-certainty. Arditi et al. (2017) noted the following 
limitations for the systematic review: (a) evidence certainty because of low level of evidence and 
quality ranking, (b)methodology, (c) inconsistency, and (d) wide confidence intervals of the 
utilized studies. The authors provided the following recommendations for future studies: (a) 
reminders be used in a variety of settings, (b) leave space on the reminder for responses for the 
HCPs, (c) explanation of the content of the reminder, and (d) provide relevant sources with large 
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effect sizes. Arditi et al. (2017) concluded with moderate certainty that the quality of care of 
patients moderately improved when HCPs received computer generated reminders delivered on 
paper regarding CPG compliance. No theoretical framework guided this systematic review. The 
PL rated this systematic review as a level-II, using the level of evidence scale, and gave this 
review an A quality rating.  
 Zahanova et al. (2017) performed a pilot study utilizing the iSCREEN Diabetes 
Dashboard at a pediatric diabetic clinic during point of care visits. The researchers hypothesized 
that CPG adherence by HCPs, knowledge of CPGs, and easy access to guidelines and patient 
information would improve through utilizing the CDSS. iSCREEN was implemented to assist in 
preventing overscreening, as well as to remind HCPs when testing was needed, as based on 
the Canadian Diabetes Association (2013) CPGs for the Prevention and Management of 
Diabetes. This study included 50 adolescents, who were between the ages of 14 to 18, and had 
a diagnosis of type 1 diabetes. Twenty-five charts were reviewed during the pre-intervention 
phase and 25 charts were reviewed during the post-intervention phase. To obtain baseline 
knowledge of pre-intervention practice behaviors, five charts from five different endocrinologist 
were reviewed. The researchers used a convenience sample and the first five eligible patients, 
of that year, were selected to have their charts reviewed. The researchers stated they took all 
precautions to eliminate bias, though they noted that bias may exist. Patients were excluded 
from the study if they were enrolled in another study, had celiac disease screenings that needed 
to be performed, or were adolescents who were diagnosed with T2DM. The researchers 
screened subjects for microalbuminuria, retinopathy, thyroid disease, dyslipidemia, and HTN 
using three different categories (i.e., adequate, inadequate, or over screened). HCPs were 
given a pre-test and post-test survey, which consisted of 10 multiple choice questions and three 
Likert scale type questions, that was used to assess HCPs knowledge of CPGs, as well as 
access to CPGs. Zahanova et al. (2017) addressed the following in their study: 
 frequency of adequate screening of complication and comorbid conditions, 
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 scores on knowledge questionnaires, and  
 relative ease of access to guidelines and patient information with the launch of 
iSCREEN dashboard.  
Upon the implementation of the intervention (i.e., post-intervention), underscreening and 
overscreening decreased (p = 0.03) for nephropathy screening.  Furthermore, the amount of 
initial nephropathy screening improved. Initial retinopathy screening also improved (p = 0.04). 
Dyslipidemia and thyroid function screening showed no statistically significant change. 
Hypertension screening had no statistically significant change from 90% at baseline. Pre-
intervention (n = 31) and post-intervention (n = 27) surveys were collected. Following the 
successful launch of the CDSS iSCREEN, an 11% improvement of knowledge of CPGs was 
noted. This pilot study supported Zahanova et al.’s (2017) hypotheses that knowledge of CPGs, 
easy access to guidelines, and knowledge of patient information, in CDSS, can improve 
adherence to CPGs among HCPs. Zahanova et al. (2017) provides the following limitations: (a) 
retrospective study, (b) small and feasible sample size, (c) the control group was historical, (d) 
invalid knowledge questionnaires, and (e) the inability to perform a power analysis prior to 
beginning the study. The researchers suggested the iSCREEN tool be used in PCP offices and 
diabetic education clinics. Zahanova et al. (2017) further suggested future studies should be 
conducted long term to evaluate if knowledge translation retention improved, and to evaluate 
patient outcomes and iSCREENs cost to healthcare. The researchers concluded that guideline 
compliance can have an impact on healthcare cost and patient outcomes when incorporated in 
the iSCREEN tool. There was no discussion of IRB approval nor was there a theoretical 
framework used to guide this study. The PL rated this systematic review as a level-II, using the 
level of evidence scale, and gave this review a B quality rating. 
 Rokstad et al. (2013) conducted a pilot study to improve patient referrals to specialist by 
general practitioners (GPs). This study was conducted at outpatient clinics of Haukeland 
University Hospital, which receives approximately 2400 annual patient referrals. For this study, 
PREVENTING PRIMARY CVD: CPG COMPLIANCE  37 
 
37 
 
an electronic optional guideline tool was used in 93 GP offices to assist in the referral process 
for patients who presented with sleep apnea, chronic obstructive pulmonary disease, and lung 
tumors. EMR systems were updated at 93 GP offices to include the electronic optional guideline 
tool. The control group consisted of 117 GPs whose EMR systems were not being updated; 
therefore, normal practice for referral to specialist continued. The researchers compared the 
intervention group to the control group. Both groups were evaluated without their knowledge. 
Referral consideration and management was timed. The anonymous evaluation form was 
scored on a 0-10 scale, based upon referral diagnoses. The researchers conducted telephone 
interviews with GPs who were part of the intervention group. Information obtained during 
telephone interviews included details about system usage, ease of use, the time used to write 
referrals, and feelings about referral improvement. Rokstad et al. (2013) analyzed the variables 
referral time and total score collected on the anonymous evaluation forms using a between-
group design. During this study, there were 1080 new referrals for patients who presented with 
sleep apnea, chronic obstructive pulmonary disease, and lung tumors. The researchers stated 
that 664 referrals were from GPs; however, it was unknown if the GPs were from the 
intervention group or the control group. One can assume that GPs were from the intervention 
group. Anonymous evaluation form analyses noted a 30% rate of referral improvement from 
GPs to specialist in all diagnostic groups. There were no significant differences in referring 
patients for a chest x-ray (p = 0.142) and CT thorax (p = 0.234) when the suspected diagnosis 
was a lung tumor. The researchers also assessed for burnout among members of the 
intervention group and found no significant difference between groups. Those who were in the 
intervention group spent 34% less time on referrals, as compared to those in the control group. 
The intervention group began with 93 GPs; however, only 82 GPs reported that they had utilized 
the new electronic optional guideline tool. Of the 82 GPs who utilized the tool, 96% stated the 
tool was useful, saved time, and was easy to utilize. Rokstad et al. (2013) noted the following 
limitations to this study: (a) non-randomization of the Bergen GPs which created bias, (b) 
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inability to differentiate whether the GP was a specialist, and (c) some of the referrals included 
were not from the GPs in the study. The researchers did not provide suggestions for future 
studies but, they addressed how this study addressed suggestions from past studies. The 
researchers concluded that implementation of the electronic optional guideline tool should be 
used in a variety of setting because it saves time, will assist with efficiency and quality of care in 
outpatient clinics regarding referrals. The researchers did not use a theoretical framework to 
guide this study. The PL rated this systematic review as a level-II, using the level of evidence 
scale, and gave this review a B quality rating. 
Level-III evidence. A quantitative nonexperimental study; explanatory mixed methods 
with only level III quantitative study; exploratory, convergent, or multiphasic mixed methods 
studies; systematic review of a combination of RCTs, quasi-experimental, and nonexperimental 
studies, or nonexperimental studies only; or qualitative study or systematic review of qualitative 
studies, with or without a meta-synthesis (Dang & Dearholt, 2018, p. 130).  
There were two sources of level III evidence (Fiks et al., 2015; Regan, 2017) used for this EBP 
project.  
Fiks et al. (2015) hypothesized that an increase of clinical decision support (CDS) 
system implementation would result in an increase of feedback on performance. The 
researchers had three aims for this study (Fiks et al., 2015, p. 492): 
1) characterize patterns of adoption of the CDS, 
2) assess the impact of performance feedback on CDS adoption by primary care 
clinicians, and 
3) measure the impact of CDS use on guideline adherence. 
Clinical decision support systems were to be received by 16 practices, which were randomized 
by the researchers. A second randomization of practices was completed. This randomization 
was determined by the practice level to physician performance feedback. However, some 
practices were not randomized. HCPs who regularly treat patients who have otitis media, acute 
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otitis media, otitis media with effusion diagnosis, and children ages 2 months through 12 years 
were included in this study. HCPs who had 25 or fewer patients who have otitis media were 
excluded from this study. This study is an extension of a previous study conducted by Forrest et 
al. in 2013. Interventions of this study included study explanation, education about otitis media 
CPGs, and the use of CDS. Feedback regarding baseline data was given after 1 year of CDS 
implementation. During the next 10 months, the researcher’s hand-delivered six rounds of 
feedback to the randomized sites. The control group did not receive feedback or any further 
interaction; however, they had access to CDS. To measure adherence to acute otitis media 
guidelines, four measures were utilized, which includes: “(a) appropriate use of amoxicillin as a 
first-line antibiotic, (b) use of high-dose amoxicillin, (c) pain assessment, and (d) analgesia use” 
(Fiks et al., 2015, p. 496). 
 Fiks et al. (2015) noted that CDS otitis media tool adoption rates were low. In fact, the 
tool was never utilized by two clinicians. Furthermore, 12 of the clinicians did not use the CDS 
tool after the 3-month trial period. The CDS was utilized in less than 10% of the visits by 38.9% 
of the HCPs. At 10-25% of the visits the CDS tool was used by 20.3% of the clinicians. Further, 
30% of clinicians used the CDS tool during 21.3% of visits. The CDS tool was utilized an 
average 16.8% based on practice level. Practices that saw fewer otitis media patients were 
more inclined to utilize the CDS tool. The CDS tool was more heavily utilized during sick visits 
as opposed to well visits. The CDS tool was utilized in children 2-5 years old but less in children 
less than 6-months (p = .05), and children at high risk for adverse outcomes (p = .02). 
Feedback increased a practice’s usage of CDS, especially among practices that 
received the multifactorial intervention as compared to practices that received the single CDS 
intervention tool (Fiks et al., 2015). Practices had a 2.2%-point increase in CDS tool usage with 
feedback compared to 6.8% decrease in non-feedback practices when compared to baseline 
data. The CDS tool usage with feedback increase was statistically significant (p = .001) with a 
relative difference of 9.0% points regarding the 10-month and 12-month comparison. 
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Otitis media CPG adherence in association with CDS usage improved adherence among 
HCPs regarding CPGs. There was a relative increase of 7.5 (p < .001) and 8.6 (p = .01) in CDS 
usage in acute otitis media care with and without effusion. Pain treatment had a 48.2%-point 
relative increase for all types of otitis media. Amoxicillin, prescribed as first-line therapy, had a 
5.4%-point relative increase. Furthermore, there was a 4.9% relative point increase among 
patients who had a penicillin allergy who were prescribed the appropriate antibiotic. High-dose 
amoxicillin prescription rates had a 17%-point relative increase (Fiks et al., 2015). Unfortunately, 
the researchers noted that a 2.7% relative increase in non-indicated antibiotic prescriptions 
occurred. A CPG improvement rate of 12% was noticed in otitis media with effusion diagnosis. 
Rogers’ theory of diffusion of innovation (1970, 1986, 1990) was utilized as a theoretical 
framework to guide the study by Fiks et al. (2015). The implementation of the CDS for this 
project is innovative to its users. Fiks et al. (2015) projected that physicians will fully convert to 
utilizing the CDS instead of the using the normal process of decision making. The interventions 
were not complicated, testing did not take a significant amount of time, and the benefits were 
noticed by users. Feedback was an intervention to assist participants to recognize the benefits 
of the CDS. The context from conversations held during feedback visits evaluated the use of 
CDS for otitis media. Some HCPs felt EHR benefitted their practice, while others felt that EHR 
involved too many button clicks and was too burdensome to use for patients who expressed 
multiple complaints. Some HCPs also preferred typing notes themselves due to the complex 
nature of the CDS tool. Overall, the results of this study demonstrated that HCPs who had low 
guideline compliance benefitted the most from the CDS tool. The researchers noted limitations 
for this prospective cohort study included: (a) the study was evaluated based on the description 
of CDS tool adoption, (b) instead of randomization, and (c) it was conducted in one healthcare 
system. Suggestions made by the researchers for future improvements are to evaluate the 
independent effect of CDS adoption on patients’ diagnosis and chief compliant. The PL rated 
this study as having level-III evidence and provided an A grade for quality of the evidence.   
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 Regan’s (2017) study aimed to improve the knowledge of HCPs regarding chronic 
kidney disease, as well as to improve awareness of CPGs to increase early point of care 
referrals to nephrologists. The study was conducted in an organization composed of 80 HCPs, 
who worked in 11 primary care offices. No nephrology group was affiliated with the organization 
where this study occurred. The JBNEBP model guided this study, since the model focuses on 
EBP implementation in the clinical setting. In the study’s setting, there were 60,985 active 
patients (pre-implementation). After intervention implementation, 64,577 patients were seen. 
The study used an anonymous optional survey to assess HPCs knowledge about chronic 
kidney disease. Upon the completion of the anonymous optional survey, during a stakeholders’ 
meeting, details regarding vital baseline patient data, an educational presentation about chronic 
kidney disease and tutorials about the CDS pathway was provided to stakeholders. Since not 
every HCP was able to attend this stakeholders’ meeting, educational materials were sent to 
every HCP. Reminders regarding the chronic kidney disease project and measures was sent 
during the first month of implementation. The CDS intervention was evaluated for progress and 
improvement areas. Feedback about the projects progress and improvement was sent via email 
to HCPs. Three months after implementation of the CDS intervention, data collection began. 
The researchers performed a post-intervention survey to assess HCPs knowledge. Participation 
in this survey was optional. Patients who were 18 years and older and arrived at their schedule 
appointments were included in this study. Patients were excluded if they were inactive patients 
or passed away during the time of the study. During this study, the following variables were 
evaluated: diagnosis of chronic kidney disease, stage 3-5 chronic kidney diagnosis, diabetes 
and chronic kidney disease, HTN and chronic kidney disease, estimated glomerular filtration 
rate < 60 ml/min and < 30ml/in with or without diagnosis of chronic kidney disease, chronic 
kidney disease or estimated glomerular filtration rate < 60 ml/min with albumin/creatinine ratio 
results, chronic kidney disease linked nephrology referrals, and patients with estimated 
glomerular filtration rate < 30 ml/min or albumin/creatinine ratio (ACR) > 300 mg/g with a 
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nephrology referral. Forty-four of the 80 HCPs completed the optional survey at baseline and 23 
HCPs completed the post-intervention survey. Laboratory testing specific for chronic kidney 
disease (Z = -2.00, p = .046), chronic kidney disease stages interpretation (Z = -2.83, p = .005). 
Patient who presented with a diagnosis of chronic kidney disease, overall assessment improved 
significantly (Z = - 2.41, p = .024). Overall knowledge regarding chronic kidney disease greatly 
improved (U= 335.50, p = .01). Patients who were referred to a nephrologist as well as patients 
who were recently diagnosed with chronic kidney disease, regardless of the variable evaluated 
(e,g, glomerular filtration rates less than 60 ml/min or urine microalbumin test with an 
albumin/creatinine ratio results), significantly improved. The findings of this study were 
consistent with previous research studies that support PCPs using CDS at point of care visits to 
for chronic kidney disease guideline dissemination and algorithm management (Regan, 2017). 
Regan (2017) provided several limitations in this study: (a) generalizability, (b) homogeneity, (c) 
composition of the organization, (d) a small number of HCPs responded to the survey, (e) 
knowledge deficits of existing survey because it was sent to their work email, (f) only physicians 
received the CDS tool education etc.). The researcher suggested HCPs in primary care 
increase their knowledge base and awareness about chronic kidney disease and incorporate 
ways to promote guidelines using a CDS tool. For detection of early stages of chronic kidney 
disease, a large-scale research study with risk stratification is suggested. Regan (2017) 
concluded that chronic kidney disease guidelines be followed through a CDS tool by HCPs. 
CDS tools assist PCPs with detection and management of chronic kidney disease, assist with 
healthcare cost, and improves the care and safety of patients. The PL rated this systematic 
review as a level-III, using the level of evidence scale, and gave this review a B quality rating. 
Construction of Evidence-based Practice 
Synthesis of Critically Appraised Literature 
This literature review provided information about numerous strategies that HCPs can 
utilize to follow recommended evidence-based CPGs. Breaking down barriers held by HCPs 
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about implementing CPGs can be done by using various educational strategies (i.e. face-to-face 
presentation, computerized education, etc.), tailoring CPGs to ensure user friendliness, 
developing different versions of CPGs (i.e. for organizations and another public or media use), 
and promoting strategies to inform HCPs that new CPGs recommendations are available 
(Flodgren et al., 2016) are critical to ensure CPGs are implemented for improved patient 
outcome. When CPGs are not followed, patient outcomes are less than optimal. Therefore, it is 
imperative for HCPs to select the best strategy to implement CPGs in their daily practice, 
thereby ensuring that CPG utilization is easily supported, efficient, and effective.  
Although several studies focused on a single approach to CPG adherence (Arditi et al., 
2017; Pantoja et al., 2014; Regan, 2017; Rokstad et al., 2013; Shojania et al., 2009; Zahanova 
et al., 2017), other studies supported the use of a multi-modal approach (Fiks et al., 2015; 
Flodgren et al. 2016; Hendrix et al., 2015; Ivers et al., 2012; Li, 2018). Education is an important 
intervention for HCPs to learn about CPGs. Education alone is not an effective strategy for 
improving CPG adherence among HCPs. Historically, paper alerts were used as a strategy to 
prompt HCPs about patient needs; however, with the usage of computer/electronic systems, 
paper prompts are not being utilized as often as they once were. Unfortunately, issues arise 
with computer/electronic alerts. For example, HCPs are inundated with numerous 
computer/electronic alerts, which cause alert fatigue, thereby resulting in ignored or overlooked 
alerts (Hendrix et al., 2015; Shojania et al., 2009; Zahanova et al., 2017). Regardless, 
researchers have noted that CDSS, computer-generated alerts, or EMR systems have been 
beneficial and effective in ensuring HCPs adherence (Fiks et al., 2015; Hendrix et al., 2015; 
Shojania et al., 2009; Zahanova et al., 2017). Visual cues in the form of flowsheet (Appendix B) 
are an easy and concise intervention that will assist HCPs follow CPG recommendations. 
Flowsheets helps reading and understanding CPGs less time consuming. Audit and feedback 
can improve adherence among HCPs, specifically about following CPG recommendations. 
Providing feedback to HCPs makes them aware that improvement is necessary regarding 
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following CPGs. No matter what strategy HCPs implement, it is critical that they use this 
strategy/resource on a continuous basis, thereby resulting in improved patient outcomes.  
Best Practice Model Recommendation 
  Evidence shows that the best way to facilitate CPG compliance among HCPs is for 
computer prompts as reminders be placed in the EMR system. Shojania et al. (2009) suggested 
CPG compliance is best with computer prompts, but better compliance is noted with computer 
prompts at point of care visits. Zahanova et al. (2017) suggested CDSS improves CPG 
compliance because it provides HCPs with easy access to CPGs, knowledge about CPGs and 
access to patient information. Rokstad et al. (2013) stated that although HCP were given an 
option of using the electronic optional guideline tool that it was bypassed by some HCPs. 
Rokstad et al. (2013) stated that HCPs who utilized the electronic optional guideline tool found it 
was advantageous when treating patients. Fiks et al. (2015) found mixed reviews about CDS 
tools from HCP. Some HCPs found the CDS tool feasible for their practice while other 
suggested the CDS tool was too time consuming (Fiks et al., 2015). Arditi et al. (2017) 
suggested computer-generated reminders be delivered on paper with or without another 
intervention improved CPG compliance. Hendrix et al. (2015) noted EMR system reminder 
fatigue; therefore, HCPs bypassed and disregarded the reminder prompts in the EMR system. 
Hendrix et al. (2015) suggested using hard stops as an intervention to prevent HCPs from 
bypassing CPG recommendations in the EMR system.  
How the Best Practice Model Will Answer the Clinical Question 
The best practice model will be used to answer the clinical question, “For healthcare 
providers in a primary care setting, does incorporating a multi-modal approach that involves 
education, using computer-generated paper reminders at point of care, visual cues, and 
ongoing feedback about prescribing performance improve the initiation of medication therapy for 
the prevention of primary CVD in at-risk adult patients in a 7-week period?” Incorporating all 
elements and sub-elements of the PARiHS framework and giving equal value to each element 
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allowed for successful EBP implementation to occur. The major elements of evidence, context, 
and facilitations were essential to implementing CPGs into practice (Kitson et al., 1998). 
Computer-generated 10-year ASCVD calculated risk factor calculations were delivered 
to HCPs on paper. These scores served as a reminder to initiate a statin and/or aspirin for 
patients at-risk for primary CVD. The PL conducted an educational intervention about the 
benefits of using evidence-based practice CPGs to prevent primary CVD. Thus, this educational 
intervention will keep HCPs abreast of the need to initiate a statin and/or aspirin in patients’ at-
risk for primary CVD. The context where this EBP project was conducted was a very busy, fast 
paced practice. Given the nature of pace in this practice, medical assistants were responsible 
for performing the 10-year ASCVD risk factor calculation, which was given to HCPs, which did 
not drastically change the workflow for HCPs. Teamwork, communication, and knowledge 
regarding how to perform the PCE, for appropriate patients, resulted in smoother project 
implementation during the first week. Focusing on all elements and sub-elements of the 
PARiHS framework helped the project leader answer the clinical question guiding this evidence-
based practice project. 
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CHAPTER 3 
IMPLEMENTATION OF PRACTICE CHANGE  
Evidence-based practice can greatly assist in changing practice behaviors. Groomed to 
be leaders and change agents, DNP prepared nurses can make long-term/long-lasting 
healthcare practice changes. “Practicing in the clinical setting provides an environment for the 
DNP graduate clinician to develop and utilize skills pertaining to evaluating, integrating, and 
implementing EBP” (Chism, 2016, p. 76). Doctor of nursing prepared nurses are often able to 
make contributions through the application of knowledge and scholarship (Boyer, 1990; Chism, 
2016), thus providing institutions with the best evidence available to improve the future of 
nursing care.  
This EBP project took place in a Midwestern urban community-based clinical setting. The PL 
evaluated whether patients 40-75 years of age, who are at-risk for primary CVD, were receiving 
statins or aspirin (which is recommended by the ACC/AHA, AHA/ADA CPGs, and USPSTF). 
During this project, a multi-modal approach that included four strategies was implemented:   
1. Education was used to provide the latest CPGs to prevent primary CVD. Computer-
generated reminders, on paper, were introduced at point of care visits to alert HCPs 
about patients who had a diagnosis of dyslipidemia, HTN, and/or T2DM.   
2. The Pooled Cohort equation was utilized to calculate at-risk patients 10-year estimated 
ASCVD risk factor. Once the ASCVD computer-generated calculation was obtained, the 
office staff printed out the calculation, wrote the patient’s medical record number in the 
upper right-hand corner then made it accessible to HCPs during point of care visits. An 
estimated ASCVD 10-year risk factor greater than or equal to 7.5 mg/dl on the PCE and 
an at-risk diagnosis alerted HCPs to prescribe a statin and/or aspirin, which is based on 
CPGs. 
3. For the visual cues, copies of the CPG flowchart (Appendix B) were placed in each 
examination room as a quick reminder.  
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4. Patient charts of all three participants were audited and feedback was provided to HCPs 
on a weekly basis via letter format. 
Participants and Setting 
This project took place in a low-income urban walk-in clinic located in the Midwestern 
region of the United States. In this walk-in clinic, there are a total of six staff members. The staff 
members consist of three HCPs (one physician and two nurse practitioners), two medical 
assistants, and one office manager. Participants included in this evidence-based project 
consisted of a physician and two family nurse practitioners who have prescriptive authority. 
Participants excluded from this study are those who worked in the primary care office but, did 
not have prescriptive authority. Although the medical assistants were not participants in this 
EBP project, they played a vital role by collecting data from patient charts, inputting the data into 
the PCE at point of care visits, printing off the computer-generated PCE then placing it in the 
examination room on the computer for the HCP to obtain. 
The physician had stated to others that he is comfortable with his daily practice and is 
not interested in following CPGs. The newest FNP has less than 3 years of experience and 
works closely with the physician. The other FNP has over 10 years of clinical experience but 
stated, “there is no time to read through CPGs.”   
In 2018, it was projected that approximately 500 patients were seen per month (T.J. 
Harvey, personal communication, July 5, 2018). Many of the patients seen at the clinic have 
several comorbidities, which include dyslipidemia, HTN, T2DM, and obesity. Additionally, many 
are smokers. T. J. Harvey (personal communication, April 24, 2018) stated, “this is a great 
project and is necessary in this office.”  
Outcomes 
The targeted outcome was to improve compliance among HCPs with prescribing statins 
and/or aspirin for the primary prevention of CVD among at-risk adult patients. This 
recommendation was based upon the standards set forth by Fox et al., 2015; Stone et al., 2013; 
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Whelton et al., 2016; USPSTF (2016) in the CPGs. The PCE was utilized to calculate the 10-
year ASCVD risk factor for patients who had a diagnosis of dyslipidemia, HTN, and/or T2DM, 
which assesses an individual’s risk for a cardiovascular event. Adherence was determined by 
using chart audits, which were conducted before, during, and following the intervention.  
Intervention 
The interventions used in this project included a multi-modal approach, which 
encompassed four strategies: (a) education, (b) computer-generated reminders on paper, (c) 
visual cues, and (d) audit and feedback to assist in improving HCP compliance (i.e., prescribing 
statins and/or aspirin for the primary prevention of CVD. Education about the ACC/AHA (Stone 
et al., 2013, 2018), AHA/ADA (Fox et al., 2015) CPGs and the USPSTF (2016) to prevent 
primary cardiovascular disease among at-risk patients who had an ASCVD of greater than or 
equal to 7.5% was provided to HCPs, the medical assistants, and office manager. Education 
was also provided regarding how to utilize and where to locate the PCE on the AHA and ACC 
website. Demonstration by the PL and redemonstrations of completing the PCE was performed 
as part of the educational phase. This education was provided to the medical assistants and the 
office manager; however, the office manager stated, she would not be able complete any 
ASCVD risk factors because of her workload (S. Sams, personal communication, October 5, 
2018).  
Although evidence showed that best practice involves reminders embedded in the EMR, 
the affiliated hospital did not want to change the EMR system because organizational leaders 
believed a change in the EMR would interrupt HCPs workflow throughout the system. 
Therefore, computer-generated paper reminders were selected as the intervention. During 
point-of-care visits, the medical assistants collected patient data from their charts  regarding 
ethnicity, gender, age, current blood pressure, LDL-C, high density lipoprotein (HDL), total 
cholesterol, history of T2DM, current, former or never a smoker and whether the patient is on a 
statin, aspirin, and/or blood pressure medication input this information into the PCE to calculate 
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the 10-year estimated ASCVD risk factors of at-risk patients.  Once the estimated 10-year 
ASCVD risk factor calculations were generated from the computer utilizing the PCE from the 
AHA or ACC website, the medical assistant printed the results. To ensure that calculations was 
made quickly, the PCE remained open on computers. The medical assistant who performed the 
PCE wrote the patient’s medical record number, as the patient identifier, in the upper right-hand 
corner of the paper. The printed calculation informed the HCPs that a patient's ASCVD risk is 
greater than or equal to 7.5 mg/dl.  
When at-risk patients were taken to the examination room by the medical assistant, the 
printed computer-generated calculation was placed on the computer in the patients’ examination 
room; however, at times it was placed in the box outside of the patients’ examination room for 
the HCP to access and review. By providing the computer-generated PCE calculations, the 
paper reminder was readily available to HCPs, when they provided care, thereby increasing the 
likelihood that preventative medication was initiated.  
To ensure visibility of the CPG, the PL placed copies the CPG flowsheet (Appendix B) in 
each examination room. The flowcharts served as a quick reminder of the CPGs. The 
flowsheets provided information to HCPs regarding how to follow the recommended CPGs for 
at-risk patients with an ASCVD greater than or equal to 7.5%.  
To provide feedback, the project leader performed weekly chart audits. Weekly chart 
audits included randomly selecting five patients from each of the HCPs and evaluating 
compliance rates among HCPs. Aggregated data regarding compliance or issues with initiating 
a statin and/or aspirin were presented to the HCPs with a weekly feedback letter because the 
HCPs were never in the office together. Monthly lunches were provided to the staff as a 
celebration of short-term goals. During the monthly lunches, verbal feedback was provided 
about the progression of the project. Since all HCPs are not in the office on the same day, the 
PL went to the office on physician days to buy the physician lunch, but lunch was refused 
because of the number of patients. 
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Planning 
The PL discussed the idea of conducting a project about prescribing statins to T2DM 
patients to the project liaison in April of 2018. The PL noticed several patients who came into 
the office with T2DM and were not prescribed a statin or an aspirin. The project liaison stated 
that the EBP practice topic was necessary in this clinical setting. While completing a pilot chart 
audit in August 2018 to evaluate if conducting an EBP project about prescribing T2DM patients 
a statin and/or aspirin, it was noted that patients who were diagnosed with dyslipidemia and 
HTN also did not have a statin or aspirin prescribed as recommended by the evidence-based 
CPGs. Evaluating the pilot data, the PL noticed that more patients with T2DM were prescribed a 
statin. Communication occurred between the PL and the liaison about T2DM and statins. The 
project liaison informed the PL that insurance companies were now sending correspondences to 
the office as a reminder to HCPs to prescribe a statin to all T2DM patients. The PL and the 
project liaison then discussed completing the EBP project about prescribing statins and/or 
aspirin to patients who were diagnosed with dyslipidemia, HTN, and T2DM.  
The PL then communicated with the physician in the office about conducting this EBP 
project in the office; however, all details were not revealed because the PL did not want to 
introduce bias or the Hawthorne effect. The PL found after several literature searches about the 
best evidence for HCP to comply to CPGs was prompts in the EMR system. After the approval 
was given by the physician, the PL communicated face-to-face and email correspondences with 
several individuals at the affiliated hospital about incorporating an EMR alert system into the 
current electronic database for the medical assistants to complete for each at-risk patient’s 
during triage. Later, the PL was informed by individuals at the affiliated hospital that changes to 
the EMR was unable to be made for this EBP project because it would disrupt HCP flow in the 
office and the changes could not be made for one office.  
After rejection of computer prompts in the EMR system by the affiliated hospital, the PL 
searched the literature to find the next best option for HCP to adhere to CPGs. The next best 
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option found in the literature was computer-generated alerts printed on paper as reminders for 
HCP to adhere to CPGs. Interventions about audit and feedback were also discovered in 
several research articles during the literature search. The PL decided to perform weekly chart 
audits about the HCPs compliance with prescribing a statin and/or an aspirin to at-risk patients 
based on the research articles read. The PL discussed with the medical assistants and the 
office manager that an EBP project was going to be performed at this urban walk-in clinic. The 
PL informed the medical assistants and office manager that their help was going to be needed 
to complete this project. All parties agreed to assisting with the EBP project. After deciding 
which appraisal tool, change theory, and EBP model to guide this EBP project, the PL sent 
email correspondences to Johns Hopkins and John Kotter for permission to utilize their 
information for this EBP project. Permission was not needed from the ACC and AHA to use their 
information for this EBP project. 
The PL created a PowerPoint presentation to educate the HCPs, medical assistants, 
and office manager about the urgent need of the EBP project in this clinic. The PL taught the 
medical assistants and the office manager how to obtain the PCE to calculate the 10-year 
ASCVD risk factor using the website. The PL explained that their roles in this EBP project was 
the gatekeepers.  
Data 
Data were collected before, during, and after the intervention. Chart audits included 
patient data to evaluate HCPs adherence to prescribe a statin and/or aspirin if patients had a 
diagnosis of dyslipidemia, HTN, and/or T2DM and were ages of 40-75 and never had a 
cardiovascular event which included stroke or open-heart surgery. The patient’s medical record 
number was utilized as a patient identifier; however, only the PL and academic advisor had 
access to this. It is important to note that age and gender information were necessary in the 
PCE to obtain patients 10-year ASCVD risk factor. All data were placed in an Excel spreadsheet 
then transferred to SPSS version 22.   
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To be compliant with confidentiality rules and Healthcare Insurance Portability and 
Accountability Act (HIPPA), after point of care visits paper reminders were placed in a manila 
folder by the office managers desk or in the physicians’ outbox. Computer-generated paper 
reminders placed in the physician outbox were then retrieved by the PL or the medical 
assistants then placed in a manila folder, which was kept at the front desk. The PL collected the 
computer-generated reminders which displayed patients 10-year ASCVD risk factor on a weekly 
basis. The computer-generated reminders are locked in a file drawer in the PL’s home. Data 
typed in the Excel spreadsheet on the PL’s computer were and continue to be password 
protected and saved on a universal serial bus (USB) flash drive which was and continues to be 
kept in a locked file drawer. At the end of the project, the computer-generated paper reminders 
and chart audit data will continue to be kept in a locked filed drawer in the PL’s home until the 
time limit has been reached for it to be destroyed. The PL and EBP project advisor are the only 
people who had access to the data.  
Measures and their Reliability and Validity 
The PCE was used to measure a patient’s ASCVD 10-year estimated risk factor which 
tells patients risk for primary CVD. The PCE can be located on the AHA or ACC website: 
http://static.heart.org/riskcalc/app/index.html#!/baseline-risk or http://tools.acc.org/ascvd-risk-
estimator-plus/#!/calculate/estimate/. The PCE is a reliable and valid tool to obtain patients 10-
year estimated ASCVD risk factor as evidenced by a c-index of 0.82 in women (95% CI: 0.78-
0.86) and 0.74 (0.71-0.78) in men. Although validity was provided for the PCE, recalibration 
improved the equations performance using the Hosmer-Lemeshow Chi-square, which resulted 
in scores of 23.8 in women and 56.7 in men (Khalili et al., 2015). Emdin et al. (2016) and Khalili 
et al. (2015) postulated that although the PCE is valid but it still has flaws. The equation 
overestimates a patient’s risk of CVD by 57% in women, 48% in men (Khalili et al., 2015) and 
167% overall (Emdin et al., 2016). However, the ACC/AHA (Stone et al., 2013) CPG 
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recommends the use of the PCE, as it has been successfully used in many national and 
international studies over time (Fox et al., 2015; Garza et al., 2017; Stone et al., 2013).  
Data Collection 
When the PL piloted this study, 100 patient charts were audited to assess the project’s 
feasibility. The PL recognized that out of the 100 charts audited, 18 patients met the criteria of 
having T2DM and a 10-year ASCVD risk factor of greater than or equal to 7.5% for the initially 
planned EBP project. It was presumed that there was low number of T2DM patients identified, 
who met the criteria during chart audits, because insurance companies began sending 
reminders into the office for HCPs to initiate statins for diabetic patients (T.J. Harvey, personal 
communication, July 24, 2018). Recognizing the low number of T2DM patients, who met this 
EBP project’s criteria, the project leader decided to collect additional data. Patients who were 
diagnosed with dyslipidemia, HTN, and/or T2DM and were not prescribed a statin and/or aspirin 
were included in the study. Ultimately, the PL shifted the focus of this EBP project to include all 
patients who are at-risk (i.e., who present with dyslipidemia, HTN, and/or T2DM diagnosis) for 
primary CVD.  
The PL performed the pre-intervention chart audits during the Fall of 2018 semester, 
after IRB approval was granted. The PL randomly selected 100 patient charts for audit during 
the pre-intervention phase of this EBP project. During the audit process, the PL evaluated HCPs 
adherence to prescribing a statin and/or aspirin in patients ages 40-75 years old who presented 
with a diagnosis of dyslipidemia, HTN, and/or T2DM. During the implementation phase of the 
intervention, chart audits occurred weekly. The PL randomly selected five patient charts of each 
of the HCPs in the office. Aggregated data were provided to HCPs to provide feedback about 
adherence to the EBP project. During post-intervention, the PL randomly selected 100 patient 
charts to audit to evaluate if the HCPs are continuing to follow the CPGs by prescribing a statin 
and/or aspirin in patients at-risk for the prevention of primary CVD. 
Sample 
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The sample for this EBP project included three participants. The participants included 
one physician and two FNPs who had prescriptive authority. Although, the HCP were the focus 
of this EBP project patient charts were audited to evaluate HCP compliance with prescribing a 
statin and/or aspirin to at-risk patients. Patient charts audit included patients who were 40-75 
years of age and had been diagnosed with dyslipidemia, HTN, and T2DM. For the project, 300 
charts were audited. However, not all patients met the inclusion criteria. For example, audits 
showed that some patients had an ASCVD of less than 7.5 were not prescribed statins or 
aspirin, which although compliant with the CPGs, was not the focus of the PICOT question. 
After removing patients who did not meet the inclusion criteria, 243 patient charts were included 
in the final sample. 
Management and Analysis 
 Data, obtained through chart audits, was initially entered in an Excel spreadsheet then 
transferred to SPSS software (Version 22). Descriptive statistics were calculated to describe the 
frequency of the patient chart sample characteristics. These characteristics are detailed in Table 
4.1. The PL utilized a cross tabulation Chi-square test to analyze the compliance rates of HCP 
with prescribing statins and/or aspirin to patient with the risk factors of an ASCVD greater than 
or equal to 7.5%, dyslipidemia, HTN and T2DM (See Table 4.2 and see Figure 4.1 for details). 
Secondary outcomes about HCP prescription preference and how many patients received a 
statin only, aspirin only, both, or none based on risk factors are discussed in Chapter 5. 
Frequencies were calculated to assess the number of comorbidities that were plaguing the 
HCPs and patients at this walk-in clinic. Details about these incidental findings are discussed in 
Chapter 5.  
Protection of Human Subjects 
Expedited IRB approval was obtained through the Methodist Hospitals, Inc. and 
Valparaiso University. The PL created a proposal summary and completed the IRB for project 
approval by Valparaiso University. The PL was initially informed by an individual at the affiliated 
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hospital that IRB was not needed because the EBP project was not research. The PL continued 
to question the need for IRB at the affiliated hospital until the PL found out that IRB approval 
was necessary. The PL then completed the IRB approval for the affiliate hospital. The initial IRB 
for Valparaiso University and the affiliated hospital was returned for revising. The IRBs for both 
entities was revised and sent back. In approximately the middle to end of September the IRB for 
both entities was approved. 
The PL created a consent form (Appendix C) for the three participants (the one 
physician and two HCPs) to sign for participation in this EBP project. This EBP project began 
the first week in October 2018, in which the PL was in the office the entire week to answer 
questions and assure project initiation was a smooth transition. The PL implemented this project 
in the Fall of 2018 and completed in March of 2019 (see Table 3.1 and 3.2 for the Actual 
Timeline). 
On a weekly basis, the PL collected the paper reminders, which were placed in a manila 
folder located at the front desk. These paper reminders were put into the manila folder after 
point of care visits by the medical assistants or they removed them from the physician’s outbox. 
To protect participants, the PCE with patients 10-year ASCVD risk factor was locked in a file 
drawer, which is located in the PLs’ home. Data typed into the Excel spreadsheet, located on 
the PL’s computer, are password protected and saved on a USB flash drive. The USB is kept in 
a locked file drawer located in the PL’s home office. At the end of the project, the paper 
reminders and chart audit data will be kept in the PL’s home in a locked file drawer. The project 
leader and EBP project advisor were the only people who had access to the data collected for 
this EBP project.  
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Table 3.1  
Actual Timeline Fall 2018 
Fall 2018 Semester Weeks 
 
1 2 3 4 5 6 7 8 9 1
0 
1
1 
1
2 
1
3 
1
4 
1
5 
1
6 
Empirical Phase                 
1. IRB approval X X X X X            
2. Pre-intervention data 
collection 
      X X         
3. Staff education        X         
4. Intra-intervention data 
collection 
        X X X X X X X  
Fall 2018 Semester Weeks 1 2 3 4 5 6 7 8 9 1
0 
1
1 
1
2 
1
3 
1
4 
1
5 
1
6 
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Table 3.2  
Actual Timeline Spring 2019 
Spring 2019 Semester Weeks  
 
1 2 3 4 5 6 7 8 9 1
0 
1
1 
1
2 
1
3 
1
4 
1
5 
1
6 
Empirical Phase continued                 
4. Intra-intervention data 
collection continued 
   X X X           
5. Post-intervention data 
collection 
      X X         
Analytical Phase                 
1. Entering data in SPSS     X X X X X        
2. Data Analysis         X X       
3. Interpretation of results          X X      
4. Abstract preparation     X X           
5. Poster development        X X X X      
6. Finalizing paper         X X X      
Dissemination Phase                 
1. Discussing project results 
with stakeholders 
       X         
2. Develop project 
improvements 
recommendations 
        X        
3. Hand-off plan         X        
4. Biography preparation  X X X             
5. Abstract preparation     X X           
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6. Poster preparation        X X X X      
7. Presentations/reports            X X    
8. Utilization of findings             X X   
Spring 2019 Semester Weeks 1 2 3 4 5 6 7 8 9 1
0 
1
1 
1
2 
1
3 
1
4 
1
5 
1
6 
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CHAPTER 4 
FINDINGS 
Research has an imperative place in nursing. Through critical thinking and scholarly 
writing, research leads DNP prepared nurses to conduct EBP projects which can be used to 
improve the health of patients. The purpose of this EBP project was to alter standard practice 
among HCPs, thereby improving adherence to CPGs for prescribing a statin and/or aspirin 
among patients who have been diagnosed with dyslipidemia, HTN, and/or T2DM and have a 
10-year ASCVD risk factor of greater than or equal to 7.5%, thereby potentially preventing 
primary CVD in these at-risk patients. The PICOT question that guided this study is, “For 
healthcare providers in a primary care setting, does incorporating a multi-modal approach that 
involves education, computer-generated paper reminders at point of care, visual cues, and 
ongoing feedback about prescribing performance improve the initiation of medication therapy for 
the prevention of primary CVD in at-risk adult patients over a 7-week period?” 
 The interventions for this project included a multi-modal approach that included four 
strategies:   
1. Education was used to provide the latest CPGs to prevent primary CVD and about how 
to create computer-generated paper reminders for at-risk patients.  
2. The PCE was utilized to calculate at-risk patients 10-year estimated ASCVD risk factor. 
Once the ASCVD computer-generated calculation was obtained, the office staff printed 
out the calculation, wrote the patient’s medical record number in the upper right-hand 
corner then made it accessible to HCPs during point of care visits. 
3. For the visual cues, copies of the CPG flowchart were placed in each examination room 
as a quick reminder.  
4. Feedback was provided to HCPs on a weekly basis via letter format. 
Participants 
PREVENTING PRIMARY CVD: CPG COMPLIANCE  60 
 
60 
 
Size. Participants included in this EBP project included one physician and two nurse 
practitioners who have prescriptive authority. Descriptive characteristics for the participants 
include one male and two females. To preserve anonymity, no further descriptive characteristics 
will be provided.  
To measure the outcome, the initial sample included 285 patient charts which were audited 
during the EBP project. After assuring that patients included in the audit met the inclusion 
criteria, the final sample consisted of 234. There were 76 of pre-intervention patient charts, 75 
charts audited during the intervention, and 83 charts from the post-intervention audit.  
Characteristics. Data were collected about the three HCPs who had prescriptive authority 
regarding their prescribing a statin and/or aspirin in patients at-risk for primary CVD. Aggregated 
data will be reported to protect anonymity. Data collected during the patient chart audits 
included medical record number, gender, age, race, total cholesterol, LDL-C, HDL cholesterol, if 
the patient is currently taking a statin and/or aspirin, the patient’s current blood pressure, 
presence of a diagnosis of diabetes, if the patient is currently being treated for HTN, and 
whether the patient is a current, former, or has never smoked.  These data were necessary for 
the PCE to calculate ASCVD risk factor. 
Chi-square tests were used to determine if there were any statistically significant differences 
between the pre-intervention, implementation and post-intervention groups on the variables of 
gender and race. Results showed that there were no statistically significant differences between 
the intervention groups on these variables.  
The ages of patients ranged from 40 to 75, with an average of 58.21 years and a SD of 
7.873 years. There were more females (65%) compared to males (35%). The sample was 
primarily African American (98.7%), with two Caucasians (0.9%), and one Hispanic/Latino 
(0.4%). Eighty-nine (88.9%) percent of patients had an ASCVD greater than or equal to 7.5 
percent, (92.7%) had a diagnosis of hyperlipidemia, (88.9%) were taking HTN medication, and 
(52.6%) had a diagnosis of which required a statin and/or aspirin to be prescribed (Table 4.1).  
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Table 4.1 
 
Patient Chart Audit Sample Characteristics 
 
Variable  Pre-intervention Implementation Post-Intervention       Total 
                                         (n = 76)         (n = 75)         (n = 83)         (n = 234) 
 
Age Mean(SD) 56.87(8.646)    58.09(6.919)    59.55(7.814)    58.21(7.873) 
 
Gender 
 Female   49(64.5%)        47(62.7%)          56(67.5%)       152(65%) 
  
 Male                 27(35.5%)                    28(37.3%)                    27(32.5%)          82(35%)                                                                                     
 
Race 
 Black    76(100%)     72(96%)      83(100%)     231(98.7%) 
 
 Caucasian      0(0%)      2(2.7%)         0(0%)               2(0.9) 
 
 Hispanic               0(0%)                    1(1.3%)                         0(0%)               1(0.4%) 
 
Risk Factors* 
 
 ASCVD               65(85.5%)   71(94.7%)  72(86.7%)          208(88.9%) 
 
 Dyslipidemia      68(89.5%)   73(97.3%)     76(91.6%)          217(92.7%)  
 
 HTN       70(92.1%)   66(88.0%)  72(86.7%)          208(88.9%) 
 
T2DM     42(55.3%)           33(44.0%)            48(57.8%)   123(52.6%)                                                                                     
 
*Includes comorbidities 
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ASCVD. A patient’s 10-year ASCVD is based on a patient’s gender, age, race, total 
cholesterol, LDL-C, HDL cholesterol, if the patient is currently taking a statin and/or aspirin, the 
patient’s current blood pressure, if the patient has a diagnosis of diabetes, is currently being 
treated for HTN and whether the patient is a current, former, or have never smoked. After the 
patient’s data is input into the PCE, the 10-year ASCVD is obtained. Stone et al. (2013) state 
that patients who have an ASCVD of greater than or equal to 7.5% should be started on a 
statin; while the USPSTF (2016) recommends starting a statin and/or aspirin in patients who 
have an ASCVD greater than or equal to 10%. Descriptive statistics were used to determine the 
frequency and percentage of patients who had an ASCVD score greater than or equal to 7.5%. 
The results revealed 208 out of 234 (89%) patients had a 10-year ASCVD risk factor that met 
the criteria for this EBP project (Table 4.1). Results also revealed that 172 (73.5%) patients had 
a 10-year ASCVD risk factor greater than or equal to 10%. 
Dyslipidemia. High cholesterol was determined using an if statement to filter patients who 
had a LDL-C greater than or equal to 70. Patient who had a LDL-C greater than or equal to 70 
mg/dl have a diagnosis of dyslipidemia. Based on this criterion, the frequency of dyslipidemia 
was 217 out of 234 (92.7%) patients (Table 4.1). 
Hypertension. Clinical practice guidelines suggest patients who have a diagnosis of HTN 
and an ASCVD greater than or equal to 10% should be treated appropriately with 
antihypertensive medication(s) and started on a statin (Wheaton, 2016). Descriptive statistics 
were used to determine the number of patients being treated for HTN. Eighty-nine percent (n = 
208) was revealed to be receiving HTN treatment (Table 4.1). 
Type II Diabetes. A history of T2DM was determined by auditing patient charts of the three 
providers for this EBP project. Descriptive statistics were used to determine the number of 
patients who had a diagnosis of T2DM. Nearly 53% (n = 123) of the patients were diagnosed 
with T2DM treatment (Table 4.1). 
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Changes in Outcomes 
 The primary question for this project was based on HCP compliance with prescribing a 
statin and/or aspirin to patients who had a diagnosis of dyslipidemia, HTN, and/or T2DM and an 
ASCVD greater than or equal to 7.5%. Findings show that there were improvements from the 
pre-intervention phase to the implementation phase, while a slight decrease was noted from the 
implementation phase to the post-intervention phase. The secondary outcomes examined 
include the pattern of prescribing statins and/or aspirin, as well as comorbidities.   
Primary Outcome: Compliance with CPGs.  
During pre-intervention phase, data showed that the HCPs were compliant with 
prescribing a statin or aspirin for 47.4 % (n = 36) of the patients and non-compliant with 52.6% 
(n = 40) of the patients (Table 4.2). During the intervention, compliance increased nearly 20% 
with a compliance rate of 66.7% (n = 50). Post-intervention data revealed a slight drop in 
compliance to 63.9% (n = 53). Overall, HCPs were prescribing according to the CPGs for 59.4% 
(n = 139) of the patients (Figure 4.1). 
 Because compliance was measured as a nominal level variable, a cross tabulation Chi-
square was computed to determine if there was statistically significant improvement (Cronk, 
2018). Results showed a combined statistically significant improvement between all phases for 
compliance (X2 = 6.887, df = 2, p = 0.032) (Table 4.3).  
Secondary Outcomes: Prescribing Trends.  
Secondary analysis for this EBP project focused on the prescribing preferences of the 
HCPs and the prevalence of comorbidities. According to this EBP project prescribers could 
prescribe a statin, aspirin, or both to at-risk patients. Descriptive statistics show there was a 
slight increase for prescribing statins and aspirin as the project progressed (Table 4.4). Fifty-five 
(23.6%) patients were prescribed a statin; while 34(14.5%) patients were prescribed an aspirin, 
47(20%) were prescribed combination therapy of a statin and aspirin and 98(41.9%) of patients 
were not prescribed any medication therapy (Figure 4.2). 
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Table 4.2 
Compliance/Non-compliance 
 
Variable  Pre-intervention Implementation Post Intervention       Total 
                                         (n = 76)        (n = 75)         (n = 83)         (n = 234) 
 
Compliant  36(47.4%)       50(66.7%)          53(63.9%)     139(59.4%) 
 
 
Non-compliant  40(52.6%)      25(33.3%)          30(36.1%)      90(38.5%) 
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Figure 4.1 HCP Compliance with Prescribing Statin and/or Aspirin 
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Table 4.3 
Compliance Chi-Square Tests 
 
 Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 6.887a 2 .032 
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Table 4.4 
 
Prescribing Trends  
 
 Pre-intervention 
(n = 76) 
Implementation 
(n = 75) 
Post-intervention 
(n = 83) 
Total 
(n = 234) 
Statin 13(17.1%) 21(28.0%) 21(25.3%) 55(23.5%) 
 
Aspirin 10(13.2%) 12(16.0%) 12(14.5%) 34(14.5%) 
 
Combined 15(19.7%) 13(17.3%) 19(22.9%) 47(20%) 
 
None 38(50.0%) 29(38.7%) 31(37.3%) 98(41.9%) 
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Figure 4.2 Prescription Preferences 
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Table 4.5   
Frequency and Percentage of Prescribing Choice based on Diagnosis 
Dyslipidemia  Hypertension  T2DM 
(n = 217)  (n = 208)  (n = 123)  
Statin  51(23.5%)  47(22.6%)  34(27.6%)  
Aspirin  32(14.7%)  31(14.9%)  14(11.4%) 
Combined 41(18.9%)  45(21.6%)  37(30.1%) 
None  93(42.9%)  85(40.9%)  38(30.9%)     
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Figure 4.3 Frequency and Percentage of Prescribing Choice based on Diagnosis 
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Descriptive statistics were used to breakdown HCP prescription preference for each at-
risk category used for this project to prevent primary CVD. Prescription preference include statin 
only, aspirin only or a combination of both based on patient’s diagnosis and ASCVD risk factor. 
Dyslipidemia. Stone et al. (2013) recommends initiating a statin in patients who have a 
primary LDL-C of 190mg/dl with no 10-year ASCVD risk factor or patients who have an LDL-C 
greater than or equal to 70 mg/dl through less than or equal to 189 mg/dl with a 10-year ASCVD 
risk factor greater than or equal to 7.5%. Dyslipidemia was analyzed using descriptive statistics 
about patients whose chart audits revealed 217 had a LDL-C greater than or equal to 70mg/dl 
(Table 4.5). Analysis of HCPs prescription preference revealed that 51(23.5%) were patients 
treated with statin alone, 32(14.7%) aspirin alone, and 41(18.9%) treated with a statin and 
aspirin; while 93(42.9%) of patients with dyslipidemia did not receive appropriate medication 
therapy (Figure 4.3). 
Hypertension. Whelton et al. (2018) and Arnett et al. (2019) recommend initiating statin 
therapy in patients who have a diagnosis of HTN and a 10% or greater 10-year ASCVD risk 
factor. Descriptive statistics revealed 208 patients were being treated for HTN. Thirty-seven 
(22.6%) patients in this diagnosis category were treated with a statin only, 31(14.9%) patients 
received an aspirin only, and 45(21.6%) patients were prescribed both a statin and an aspirin 
regimen; while 85(40.9%) did not receive either medication therapy. Table 4.5 and Figure 4.3 
display the frequency and percentage of prescribing choice based on diagnosis. 
Type II Diabetes Mellitus. Stone et al. (2013) recommended that patients who have a 
diagnosis of T2DM and a 10-year ASCVD risk factor of greater than or equal to 7.5% should be 
prescribed a moderate or high intensity statin. Data showed 123 patients had diagnosis of 
T2DM. Of these, 34(27.6%) patients were prescribed statins, 14(11.4%) of the patients were 
prescribed aspirin, and 37(30.1%) patients received a combined treatment regimen of a statin 
and an aspirin; while, 38(30.9%) of patients with T2DM did not receive appropriate medication. 
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Table 4.5 and Figure 4.3 displays the frequency and percentage of prescribing choice based on 
diagnosis. 
Instrument Reliability and Validity 
The reliability and validity of the PCE instrument has been established (Emdin et al., 
2016 and Khalili et al., 2015). Cronk (2018) states instruments must be tested for reliability 
before determining validity. Validity of the PCE was tested using the Pearson correlation. A 
Pearson correlation was calculated examining the relationship between patient’s ASCVD and 
HCP compliance. No correlation was found (r = -0.079, p > 0.01). See Table 4.6 for the validity 
correlation table. 
Significance 
Significance and interpretation of the results is vital to determine whether implementation 
of the EBP project successfully changed practice. There was a statistically significant 
improvement in HCP compliance to prescribing a statin and/or aspirin in patients who were 
diagnosed with dyslipidemia, HTN, and/or T2DM. Descriptive statistics were calculated 
regarding statin and aspirin prescribing throughout this EBP project. Statistics showed improved 
HCP compliance with prescribing both statins and aspirin as the project progressed. Data did 
not show a provider preference for either statins or aspirin.  
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Table 4.6 
Validity Correlations 
 
 
What is the 
patients 
ASCVD? 
Is the 
provider 
compliant? 
Is the patient 
currently on a 
statin? 
Is the patient 
currently 
taking 
aspirin? 
What is the patient’s 
ASCVD? 
Pearson 
Correlation 
1 -.079 -.097 -.074 
Sig. (2-tailed)  .231 .137 .260 
N 234 234 234 234 
Is the provider 
compliant? 
Pearson 
Correlation 
-.079 1 .727** .492** 
Sig. (2-tailed) .231  .000 .000 
N 234 234 234 234 
Is the patient currently 
on a statin? 
Pearson 
Correlation 
-.097 .727** 1 .212** 
Sig. (2-tailed) .137 .000  .001 
N 234 234 234 234 
Is the patient currently 
taking aspirin? 
Pearson 
Correlation 
-.074 .492** .212** 1 
Sig. (2-tailed) .260 .000 .001  
N 234 234 234 234 
**. Correlation is significant at the 0.01 level (2-tailed). 
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CHAPTER 5 
DISCUSSION 
 Doctor of nursing prepared nurses demonstrate expertise when evaluating EBP projects 
by discussing statistical significance and providing recommendations for future implications. 
This provides information for future EBP projects and evidence-based bedside care. Providing 
insights about the framework, strengths, and limitations about the current project saves time for 
future nurses who to attempt a different path. The purpose of this EBP project was to alter 
standard practice among HCPs, thereby improving adherence to CPGs for prescribing a statin 
and/or aspirin among patients who have been diagnosed with dyslipidemia, HTN, and/or T2DM 
and have a 10-year ASCVD risk factor of greater than or equal to 7.5%, thereby potentially 
preventing primary CVD in these at-risk patients. It answers the PICOT question: “For 
healthcare providers in a primary care setting, does incorporating a multi-modal approach that 
involves education, using computer-generated paper reminders at point of care, visual cues, 
and ongoing feedback about prescribing performance improve the initiation of medication 
therapy for the prevention of primary CVD in at-risk adult patients over a 7-week period?” This 
chapter presents a culmination of this EBP project.  
Explanation of Findings 
Primary Outcome 
Data analysis showed there was a statistically significant increase (X2 = 6.887, df = 2, p 
= 0.032) in the prescribing of a statin and/or aspirin in at risk patients when using a multi-modal 
approach for prescribing a statin and/or aspirin in at-risk patients. There was a nearly 20% 
increase with HCPs prescribing statins and/or aspirin in at-risk patients from the pre-intervention 
phase to the implementation phase of this EBP project. However, a slight decrease was noted 
with compliance prescribing a statin and/or aspirin from the intra-intervention phase 66.7% 
compliance to the post-intervention phase 63.9% compliance. These findings are congruent with 
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findings of a previous study completed by Arditi et al. (2017) showing that computer generated 
reminders delivered on paper moderately improved CPG compliance; however, the authors did 
not report if improvement continued during the post-intervention phase of any of the research 
they reviewed. Fiks et al. (2015) reports that 11% of HCPs who used the CDS tool during the 
implementation phase trial period did not use it afterwards. These findings are congruent with 
this EBP project in that there was slight drop in adherence rates from the implementation phase 
to the post-intervention phase.  
It has been shown that when computer reminders are combined with other interventions, 
slight improvements with the adherence continued to improve when computer reminders are 
used (Shojania et al, 2009). Even more improvements were noted when hard stops are used in 
the ERM system (Shojania et al., 2009). When reminders are placed in computer systems, CPG 
adherence will increase (Zahanova et al., 2017). When general practitioners used the electronic 
optional guidelines as a tool to refer patients to specialize care continued to use it during the 
evaluation phase (Rokstad et al., 2013); however it has also been suggested that highlighted 
printed reminders were unsuccessful in improving HCPs responsiveness (Hendrix et al., 2015). 
These results are not congruent with the findings from this EBP project because there was an 
increase in compliance when using the paper reminders combined with other cues.  
In this EBP project, the issue with using the recommended best practice of computer 
reminders was an organizational barrier. If computer reminders could be placed in the EMR 
system, with or without hard stops, higher compliance rates with CPGs may have been 
achieved. This approach would have eliminated reliance on medical assistants, who were 
resistant to the added responsibility of completing the PCE. The prompt would have 
automatically filled in all the data necessary to run the PCE and provided HCPs with patients 
10-year ASCVD risk factor. 
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 Despite not using computer prompts, the improvement of compliance with CPGS by 
HCPs from the pre-intervention phase to the implementation phase are primarily attributed to 
the multi-modal intervention. However, there are some other factors that could also explain the 
increased compliance. For example, the project liaison is an employee at the project site and 
was very supportive when resistance to completing the PCEs was met. The PL taught the 
project liaison how to complete the PCEs; however, it is uncertain if the project liaison began 
completing the PCEs for patients encountered. The PL was present at the project site more 
often to ensure patients who met the requirements for having PCEs completed and given to the 
HCP were complete. The PL also helped performed PCEs and provide them to the HCPs to 
ensure successful implementation of the this EBP project.  
 While there was a slight drop in compliance from the intervention phase (66%) to the 
post-intervention phase (63%). Some other factors that could explain this drop include: (a) lack 
of oversight by the PL, (b) disagreement with CPGs, (c) non-compliance by patients because of 
medication side effects, (d) HCP not appreciating statins because of side effects, and (e) 
prescribing contraindications based on patient factors. Despite the slight drop, compliance 
during the post intervention phase remained well above the pre-intervention phase (46%). This 
provides evidence that the multi-modal intervention had some lingering effect on the prescribing 
compliance of the HCPs.   
Secondary Outcomes 
 Prescribing trends. The secondary outcome focuses on the prescribing trends of 
HCPs. The PL calculated the prescribing trends of HCP for the prevention of primary CVD in at-
risk patients. Prescribing of statins, aspirin, or both by the HCPs slightly increased from pre-
intervention to post-intervention. However, it was noted, there was no difference in prescribing 
preferences between the pre-intervention, implementation, or post-intervention phase related to 
statin, aspirin, or both (Table 4.4).  
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 Comorbidities. The incidental findings question for this EBP project was “how many 
patients in the clinic where this EBP project was conducted and whose charts were audited had 
multiple co-morbidities?” The purpose of this question was two-fold: (a) to compare this data to 
the national and state average, and (b) to evaluate the need for future DNP projects to be 
performed in the community. When considering these purposes within the context of this EBP 
project, it is important to keep in mind that patients in the sample were primarily African 
American.  
Dyslipidemia, HTN and T2DM are risk factors for primary cardiovascular disease (CDC, 
2012, 2017; Healthy People 2020, 2014). Oftentimes, HCPs care for patients who have multiple 
co-morbidities. In this EBP project, 38% (n = 89) of patients had a diagnosis of dyslipidemia, 
HTN, T2DM and an ASCVD greater than or equal to 7.5%. Forty-one percent (n = 96) of 
patients had a diagnosis of HTN, T2DM and an ASCVD greater than or equal to 7.5%. While, 
43% (n = 101) had a diagnosis of dyslipidemia, T2DM and an ASCVD greater than or equal to 
7.5%. Seventy-six percent (n = 178) had a diagnosis of dyslipidemia, HTN and an ASCVD 
greater than or equal to 7.5%. Although there appears to be an alarming number of patients at 
this project site with multiple co-morbidities that can lead to further health complications it is 
misleading because the population chosen were patients with a history of dyslipidemia, HTN, 
and T2DM. It is important to note that, although data is reported about individuals with 
dyslipidemia, HTN, and T2DM, selection bias exists in this EBP project. No data exist that 
depicts the national or states level of individuals with multiple comorbidities.  
Health disparities. Data from this EBP project shed light on the urgency to prevent 
primary cardiovascular disease in these at-risk patients, most all of whom were African 
American. In a survey conducted by the CDC (2017d) health disparity was measured by asking 
patients if they had ever been informed by their HCP that they had one of the risk factors for 
primary CVD.  
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Dyslipidemia. Health disparity data collection was conducted by asking patients if they 
had ever been informed by their HCP that they had one of the risk factors for primary CVD 
(CDC, 2017b). According to the America’s Health Rankings (2018a), in 2018 there was a 
decrease in the number of individuals who were diagnosed with dyslipidemia in the US (34.1%) 
and in Indiana (33%). Dyslipidemia was noted to increase with age nationally and in Indiana. 
Approximately 41% of individuals ages 45-64 in the U.S. and 41.7% of those in Indiana have a 
diagnosis of dyslipidemia; while those 65 and over 51.7% in the US and 54.1% in Indiana. 
African American rank number three 30.8% US and 28.5% in Indiana for being diagnosed with 
dyslipidemia with American Indian/Alaskan Native and the Asian population ranking higher. 
Selection bias exist; therefore, the PL is unable to compare the data from this EBP project to the 
national or state average. Doctor of nursing practice nurses must be aware that it is 
recommended patients be started on a statin in the current CPGs if they have a LDL-C of 190 or 
greater and if they have a LDL 70-189mg/dl and an 10-year ASCVD of 7.5% or greater. 
HTN. According to the CDC (2017c), 29.0% of individuals in the United States and 
48.6% in Indiana had a diagnosis of HTN. The prevalence of HTN increases with age and is 
higher among African Americans. Data reveal that 7.5% of adults aged 18–39 (CDC, 2017c) 
while American Health Ranking (2018c) reports 14.1% among 18-44 in the US and 16.2% in 
Indiana, 33.2% among those aged 40–59 (CDC, 2017c). American Health Ranking (2018c) 
reports in ages 45-64 40.5% in US while 44.6% in Indiana and 63.1% among those aged 60 and 
over have HTN (CDC, 2017c) while 60.5% of individuals over 65 in the US and 62.8% in Indiana 
have a diagnosis of HTN.  Racial disparity was noted with patients diagnosed with HTN. 
Approximately 41% of African Americans in the U.S. while 45.6% in Indiana was noted to have 
HTN (America’s Health Rankings, 2018c), 29.7% of Caucasians, 28.7% of Asians and 27.3% of 
Hispanics (CDC, 2017c). Hypertension has a crucial role in the prevention of primary CVD. DNP 
prepared nurses must prescribe the appropriate antihypertensive medications to patients, 
discuss lifestyle changes and initiate a statin for preventative measures. 
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T2DM. Diabetes diagnosis have shown an increase every year since 2011 (CDC, 
2017d). Centers for Disease Control (2017d) reports that 30.3M(9.4%) individuals had diabetes 
and these statistics increase with age. Seventeen percent of individuals age 45-64 years and 
25% older individuals older than 65 have a diagnosis of diabetes (CDC, 2017d). African 
Americans make up 12.7% which is the second highest prevalence nationality with American 
Indians and Alaska Native first at (15.1%) (CDC, 2017d). Approximately 12% of US individuals 
have a diagnosis of diabetes (America’s Health Rankings, 2018b). As with HTN, diabetes 
diagnosis increases based on age. Individuals aged 18-44 2.9% in the US while 3.2% in 
Indiana, aged 45-64 14.5% in the US vs 16% in Indiana and individuals older than 65 who have 
a diagnosis of diabetes 22.6% vs 24.4%. African Americans in the US with diabetes are 14.3% 
while 14.8% in Indiana (America’s Health Rankings, 2018b). Doctor of nursing practice prepared 
nurses with the inclusion of patients, must maintain a hemoglobin A1C of less than 6.5 mg/dl to 
prevention T2DM from occurring or control T2DM levels. 
Health disparity for this EBP project. Statistics for these health disparities may be 
higher in the region of the Midwestern region this EBP project was conducted because it was 
conducted in a low socioeconomic and low-income urban community. This area has no healthy 
grocery stores; therefore, patients are limited in what they can buy if they do not have 
transportation out of their community. The community has numerous fast-food and unhealthy 
restaurants in the area but no healthy options. Others may be on a fixed-income and must 
choose between healthy eating, medication, or shelter. Although, patients can exercise in their 
homes or walk around their neighborhoods, they may not feel safe. There is only one fitness 
center in the community but is not fully equipped with proper exercise equipment.  
Another aspect that must be considered is patient compliance. Patients may be in denial 
about the diagnosis they were given by their HCPs. Patients may be accustomed to eating in a 
particular manner and are not willing to change. They are not willing to take medications 
prescribed to them because of medication side effects, disbelief in the diagnosis, or affordability. 
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Lack of health literacy or lack of understanding about medications, diagnoses are contributing 
factors that play a role in the health disparities in this community. Lack of insurance and lack of 
trust with the healthcare system can account for another reason for the increase amount of 
health disparities in this community. 
Doctor of nursing practice prepared nurses are in a unique position to assist with 
combating these health disparities in this community. Doctor of nursing practice practitioners 
must educate patients about their risk for primary CVD. Several EBP projects can be initiated 
from information provided in the findings. An extension of this EBP project can involve 
examination of patient compliance with taking prescribed statins and/or aspirin. There has been 
a substantial amount of data evaluating the use of cellular phone and medication compliance. 
For example, Palmer, Barnard, Perel, and Free (2018) conducted a study about preventing 
primary CVD in at-risk patients through medication adherence using mobile devices. Doctor of 
nursing practice prepared nurses can setup a health fair in the community or at a church to 
evaluate patient’s risk for health disparities. The DNP prepared nurse can setup exercise 
sessions at the church or in a community center that is easily accessible for individuals in this 
community. 
New CPGs (Arnett et al., 2019) for the prevention of primary CVD were recently 
released. It is imperative that DNP prepared nurse practitioners are aware and knowledgeable 
of these CPGs to prevent primary CVD in at-risk patients. The CPGs state that a discussion 
regarding moderate-intensity statin should be initiated in patients who are considered borderline 
risk primary CVD (have a PCE of 5% to less than 7.5%) and a LDL-C of greater than or equal to 
70 mg/dl to less than 190 mg/dl (Arnett et al., 2019). However, patients who are intermediate 
risk (PCE of greater than or equal to 7.5% to less than 20% and a LDL-C of great than or equal 
to 70 mg/dl to less than through less than 190 mg/dl) must have a moderate intensity statin 
initiated (Arnett et al., 2019). Patients who are high risk (PCE greater than or equal to 20% and 
a LDL-C of great than or equal to 70 mg/dl to less than 190 mg/dl) must have a statin initiated, 
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but the researchers do not state whether the statin should be moderate or high intensity (Arnett 
et al., 2019). Patients who have a LDL-C greater than or equal to 190 mg/dl regardless of risk 
factors should have a high-intensity statin initiated (Arnett et al., 2019). Discontinuing the routine 
use of aspirin for the prevention of primary CVD is recommended in patients older than 70 years 
old because the risk of bleeding outweighs the benefits (Arnett et al., 2019). However, patients 
40-70 years of age and who have a high ASCVD risk factor and a low risk of bleeding can 
continue aspirin daily if recommended by their HCP. Doctor of nursing practice nurse 
practitioners must consider all factors when considering sources of information when patients 
present to their office with information they have heard or read. Information heard from the news 
or friends can be misconstrued; therefore, it is imperative that DNP nurse practitioners are well 
informed of CPGs and educate patients with facts of information presented. DNP prepared 
nurses must also consider the risk versus benefits ratio when prescribing medications to 
patients. 
Theoretical Framework 
Kotter’s 8-Step framework (Kotter, 2012) was used to guide this EBP project. Kotter’s 
framework focuses on leading change in organizations; however, it has been utilized in several 
settings including nursing. When using Kotter’s (2012) 8-step change model it must be 
understood that it is broken down into three phases. Phase one is the defrost phase which the 
transformation process is occurring which includes steps 1-4, phase two is the introduction and 
implementation of new changes which includes steps 5-7, and phase three includes continuing 
the change process and anchoring it in place to make it stick.  
Strengths in the theory that it is detailed and guides one through the process of each 
step by providing examples of successes and failures to change. Kotter (2012) clearly advises 
users of the change model that attempts to skip steps will result in failure to change practice. 
“The first step in putting together the kind of team that can direct a change effort is to find the 
right membership” (Kotter, 2012, p. 57). While there is evidence showing that reminders 
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included in EMR systems improves adherence by HCPs (Fiks et al., 2015; Rokstad et al., 2013; 
Shojania et al., 2009; Zahanova et al., 2017), individuals at the organization where this EBP 
project was conducted did not allow the PL to make changes to the EMR system. The PL was 
informed that changes would disrupt the entire organization including outpatient physician 
offices. Therefore, the PL had to implement computer-generated reminders printed on paper. 
This process included setting up a coalition to lead to project. This was discussed and 
demonstrated with the medical assists about completing the PCEs, which generate the 10-year 
ASCVD risk factors. Prior to implementation, the PL established a sense of urgency by 
providing education to all the team players of the project. Education was provided about the 
prevalence and cost of CVD in the U.S. The second step, creating the guiding coalition, proved 
to be a challenge for the PL. At the beginning of the project, the medical assistants stated they 
would assist with the project by completing the PCEs. This was a major aspect of this EBP 
project because without this information, the HCPs would not know whether their patients 
needed a statin/aspirin prescription. Medical assistants were the gatekeepers of this EBP 
project. As the PL progressed through the next steps by developing the vision and strategy and 
communicating the change vision to the team players, medical assistants were initially excited 
and happy to perform the task. However, during the implementation phase of this project the 
medical assistants resisted the change by not wanting to run the 10-year ASCVD calculations 
using the PCE. During week two of this EBP project, the medical assistants did not run any 
PCEs. Kotter (2012) states that reinforcement of previous phases needs to occur as one 
progresses to other phases. In response, the PL reinforced previous steps by reeducating the 
medical assistants on the importance and urgency of this EBP project in this community. During 
the next step, to empower board-based actions the PL educated and encouraged the medical 
assistants to replace the status-quo by completing the PCEs (Kotter, 2012). The PL continued 
to empower the medical assistants through encouragement and motivation by informing the 
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medical assistants that they are a part of a great project that will help with patient outcomes and 
prevent primary CVD in at-risk patients.  
Afterwards, the momentum increased, the medical assistants began performing the 
PCEs again; however, the PL began coming to the site more often to ensure the PCE were 
being performed and assisting with the PCE. Despite these efforts, resistance began shortly 
afterwards. Based on the chart audits and the weekly collection of the printed computer-
generated reminders printed on paper, the PL knew whether the PCEs were being performed. 
Ivers et al. (2009) suggested that important improvements are noticed in patient outcomes when 
audit and feedback are used; therefore, the PL provided weekly feedback in letter format on the 
progress of the EBP project and how many patients received medication to prevent primary 
CVD. Kotter (2012) stated, when generating short term wins, plans should be made for 
improvements and wins must be celebrated visually when creating change. An incentive of 
monthly lunches was provided twice during this EBP project to celebrate short-term wins of the 
PCE being performed and the goal of the project being met because audits revealed HCPs 
were prescribing a statin and/or aspirin to at-risk patients. In a study to evaluate incentive 
effectiveness on lipid levels the researchers found that financial incentives were more 
successful when patients and physicians jointly worked to decrease lipid levels in which both 
received an incentive (Asch et al., 2015). When working independently to receive an incentive 
for decreasing lipid levels there was not much success (Asch et al., 2015). It must be explained 
that when providing incentives for short-term wins, it means that the project is progressing well 
but has not made it to fruition. Although the lunch incentives did not improve the resistance met 
by the medical assistants, the PL would continue to generate short-term wins if this EBP project 
was performed again because it shows appreciation.  
Steps seven which are consolidating gains and producing more change, and eight 
anchoring new approaches in the culture (Kotter, 1996, 2012) were not established for this 
project. During week seven of the project, the physician called the PL into the office and 
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informed the PL that the medical assistants could no longer perform the PCEs. The project was 
abruptly ended because of the resistance and complaints from the medical assistants and the 
office manager. If the PL had to complete this EBP project again, Kotter’s 8-step change theory 
would be used again; however, the PL would not rely so heavily on the medical assistants as 
the gatekeepers to perform the PCE for at-risk patients. The PL would work harder and be more 
convincing to the stakeholders that best evidence shows computer reminders placed in EMR 
systems is the best evidence for improved patient outcomes and HCP adherence with 
prescribing a statin (Fiks et al., 2015; Rokstad et al., 2013; Shojaina et al., 2009; Zahanova et 
al., 2017).  
The timeframe of this project did not make this theoretical framework conducive for this 
EBP project because it was completed in 7 weeks. Kotter’s (2012) theoretical framework may 
have been successful if the EBP project would have been conducted over 12 weeks as 
originally planned. Therefore, with the ability to utilize best evidence-based practice in the EMR 
to ensure HCP adherence to prescribing a statin and/or aspirin, a longer timeframe would also 
be considered. 
EBP Framework 
Promoting Action on Research Implementation in Health Services framework was 
utilized as the EBP framework to guide this EBP project. According to Kitson et al. (1998), 
evidence, context, and facilitation leads to successful implementation of moving research to 
practice. The PARiHS framework was a staple for this EBP project. It helped the PL focus on 
the literature and discover the best strategies to change the practice of HCPs following CPGs 
for the prevention of primary CVD in at-risk patients. However, the context and culture of the site 
where the project was conducted was not conducive for this project. The context lacked 
appropriate leadership to establish effective teamwork amongst team players to assure this 
practice change. Evaluation was provided on a weekly basis through feedback in a letter to 
each HCP and medical assistant about the success and/or necessary improvements. 
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Facilitation was established by providing an educational session about the importance of 
primary prevention of CVD. Facilitation is similar to Kotter’s step 2 establishing a guiding 
coalition which is establishing the key players to move this EBP project forward. Resistance 
ensued during the implementation phase of this project by the medical assistants. This 
resistance made the PL go to the project site more often to ensure the PCEs were being 
performed. The PL provided another educational session with the medical assistants to 
empower them with the knowledge and to understand of the urgency of this EBP project. A 
holistic approach for facilitation was attempted by providing the medical assistants with what 
was needed for the successful implementation of this EBP project. If the PL had to conduct this 
EBP project again, the PARiHS would be utilized again. With the proper leadership and the right 
gatekeepers, research can be moved to clinical practice. Doctor of nursing practice nurses must 
understand that plans may not always lineup accordingly but with continued effort change can 
be made and the PARiHS model has all the tools to assist with successful implementation. 
Strengths and Limitations of the EBP Project 
Strengths 
The prevalence and cost of CVD, as well as the CPG recommendations about 
prevention of CVD, was established with education. Knowledge was established, as a result of 
the education provided about the PCE and the meaning of the 10-year ASCVD calculation. 
Although, this EBP project was met with resistance by the medical assistants, there was 
improvement of compliance with prescribing statins and/or aspirin to at-risk patients (see Table 
4.2). With the implementation of this EBP project, HCPs are aware of CPGs to prevent CVD in 
at-risk patients. Healthcare providers are aware of the PCE to calculate patients 10-year 
ASCVD risk factor to evaluate if a statin is necessary for at-risk patients. Based on the number 
of patients with multiple co-morbidities, HCP can emphasize medication compliance, healthy 
diet and exercise with their patients at each point of care visit. Healthcare providers can ensure 
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patients bring in their medication bottles at each point of care visit to ensure medications are 
being taken and patient do not have any questions about medications. 
Limitations 
Change is inevitable in whatever establishment one is employed; however, it is one of 
the most difficult tasks to achieve. There were two major limitations to this project: (a) resistance 
to using computer generated reminders in the EMR, and (b) resistance by the medication 
assistants to performing the PCEs.  
The inability to utilize best practice evidence which is creating hard stop computer 
prompts in the EMR system as a reminder for HCP to prescribe a statin and/or aspirin in at-risk 
patients was a limitation for the EBP project. This implementation would improve adherence 
with CPG recommendation to prevent primary CVD. Resistance with the medical assistants 
performing PCEs would not have presented a problem and the project would have had greater 
success rates with prescribing a statin and/or aspirin. Staff at this facility have established a 
routine. The staff did not prefer any new tasks that hindered that routine. This EBP project 
encountered resistance from the medical assistants to perform the PCEs to obtain patients 10-
year ASCVD risk factor as time progressed. The project site did not have many employees to 
assist with completing the PCEs. Another consideration is that the clinical site is a walk-in clinic. 
On physician days, this site can see approximately 50 patients per day; therefore, the medical 
assistants expressed they did not have time to run the PCEs. The limited timeframe of 7 weeks 
to complete this EBP project was a limitation. 
Implications for the Future 
When EBP projects are completed, DNP practitioners should give thoughtful consider to 
providing recommendations about practice, theory, education, and research. Informing others 
about these implications is vital for establishing strategies to assist with following CPGs. 
Practice  
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Doctor of nursing practice nurses must consider establishing a protocol to utilize the 
PCE for the prevention of primary CVD in at-risk patients. It would behoove organizations to 
implement hard stops in the electronic medical records which automatically input the data once 
the PCE is clicked. This would assist with HCPs to assess whether a statin is indicated for the 
primary prevention of CVD. It must also be considered that a best practice alert be established 
as a 5-year reminder about repeating the PCE. Doctor of nursing practice nurses must not pick 
and choose which CPGs are best for their clients but be open to all evidence-based CPGs. 
They must remain vigilant that all patients are unique and if a side effect occurs in one patient it 
does not mean it will occur in another patient.  
Doctor of nursing practice nurse practitioners have an important role as educators. 
Doctor of nursing practice practitioners must educate patients on the importance of medication 
adherence and possible health disparities that will can occur from not complying with 
medications. Oftentimes, medication compliance is an issue because of lack of education of 
what to expect. Therefore, patients must be educated about what side effects to expect when 
taking statins or aspirin. When patients are educated about what side effects to expect they are 
more inclined to comply with medications. It is important to establish safe open provider/patient 
relationships, so patients feel comfortable telling their clinician when issues with medications 
arise. It is essential that DNP prepared practitioners evaluate issues encountered with 
medications at each point of care visits. When issues are encountered with patients taking a 
medication it is the HCPs responsibility to begin an alternative therapy to ensure the prevention 
of primary CVD. 
Comorbidities are plaguing the community where this EBP project was conducted. 
These comorbidities will lead to primary CVD if not addressed properly. Placing DNP prepared 
nurses in a position to establish programs to assist patients with preventing comorbidities that 
lead to primary CVD is a suggestion that will combat comorbidities. Doctor of nursing practice 
prepared practitioners can create community health and wellness fairs, educational sessions, 
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group programs, and complete home phone calls to combat the comorbidities that lead to 
primary CVD in the community where this EBP project was conducted. Consideration must be 
given to all participants when attempting to establish change because each party plays a vital 
aspect to bringing successful change to an establishment.  
Theory 
One role of the DNP practitioner is to find the best theories to guide EBP projects. As 
stated above, Kotter’s (2012) 8- step change model was not conducive to this EBP project 
because of the time constraints. Kotter’s (2012) states, in his 8-step change model, failure to 
change is because individuals do not take the time to continually reinforce early stages as the 
change process moves to the next step. It is essential that step one through four are 
foundationally set before the new changes can be successfully implemented (Kotter, 2012). The 
PL educated and reinforced the purpose and importance of this EBP project as a sense of 
urgency in step five empowering broad-band action. The medical assistants expressed an issue 
with the high number of patients being seen in the office on the days the physician was in the 
office; however, the PL noticed the PCEs were not being performed when the physician was not 
in the office. This led to the PL coming into the office more frequently to assist with completing 
PCEs, but change was met with resistance. The medical assistants were resistant to change 
because of the status-quo established at this project site and lack of leadership from the office 
manager and the physician not being acceptive of statin treatment in patients because of the 
side effects. Although, Kotter’s 8-step change model was not successful at this project site, 
there a high probability that it would have been successful if hard stop computer reminders were 
placed in the EMR system for HCP’s to order a statin and/or aspirin to prevent primary CVD in 
at-risk patients. 
The PARiHS model (Kitson et al., 1998) was conducive for this EBP project; however, 
the PL was unable to move research to practice. The culture of the project site is task driven 
any deterring from the original tasks was not conducive. There was a lack of leadership at this 
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project site which is necessary for success implementation. When resistance was met, the 
leaders did not tell the medical assistants to continue the project but instead sided with the 
medical assistants which lead to the EBP projects abrupt ending. The inability to implement the 
best evidence-based practice for this EBP project hindered the evidence portion of the PARiHS 
model elements. Lack of facilitation of the organization to incorporate computer reminders into 
the EMR system for this EBP project was another reason for unsuccessful implementation. The 
process of incorporating computer reminders into the EMR system would have made 
implementation easier and facilitation would have been achieved. When using the PARiHS 
framework all elements and many of the subelements must be in place to ensure successful 
implementation. With the implementation of the best EBP the PL would use the PARiHS 
framework again. 
Research 
Research regarding aspirin and statins have changed since the inception of this EBP 
project. Therefore, prescribing practices should be updated with most recent recommendations 
used. It is recommended that future research could focus on patient compliance with taking a 
statin as prescribed be evaluated as an outcome. Another recommendation is that when a 
similar project is implemented at a larger clinical site, comparisons between NP and physician 
prescribing patterns also be evaluated to determine who is more compliant with following CPGs 
to prevent primary CVD in at-risk patients. It is also recommended that this project be changed 
to include hard stops in the electronic medical records system to alert practitioners to complete 
the PCE to obtain 10-year ASCVD risk factors and initiate a statin for at-risk patients as 
recommended in the latest CPGs. The PL recommends conducting post-intervention collection 
data from medical records of patients who had the PCE completed during the implementation 
phase instead of randomly selecting patients.  
Researchers postulated that CPGs were not being adhered to because they were too 
long and confusing (Alexander et al., 2016; Barth et al., 2016; McKee et al., 2017). It must be 
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noted that the researchers for the 2019 ACC/AHA Guidelines on the Primary Prevention of CVD 
created a Guidelines Made Simple version for ease of use and readability for HCPs and 
patients. The Guidelines Made Simple version will help with the barriers (Alexander et al., 2016; 
Barth et al., 2016; McKee et al., 2017) of HCPs adhering to CPGs. The Guidelines Made Simple 
version was decreased from 89 pages to 17 pages and flowcharts are present for each at-risk 
category for ease of flow. These flowsheets (Appendix B) can be printed out and placed in each 
examination room as a reminder for DNP prepared practitioners to utilize and follow the 
recommended CPGs for better patient outcomes. The Guidelines Made Simple version will 
assist DNP prepared practitioners educate patients about the most recent recommendations 
available for the prevention of primary CVD.  
The validity and reliability of the PCE has been questioned by several researchers 
because it provides an overestimated 10-years ASCVD risk factor score in certain populations 
(Emdin et al., 2016; Khalili et al., 2015). The authors of these studies suggest calculating 10-
year ASCVD scores improves after recalibration of the PCE (Emdin et al., 2016; Khalili et al., 
2015). Although, the criticisms are founded, the AHA and ACC continues to advise the use of 
the PCE for the calculation of patients 10-year ASCVD every 5-years. In the 2019 ACC/AHA 
Guidelines on the Primary Prevention of CVD, (Arnett et al., 2019) recommend continuing to 
utilize the PCE although it is known to overestimate and underestimate patients 10-year ASCVD 
risk factor. Therefore, patients who have a borderline or intermediate risk factor for primary 
ASCVD must have other risks evaluated prior to initiating statin therapy.  
Education  
 It is imperative that schools of nursing educate nurses in leadership skills which include 
transformational change. It must be ingrained in nursing students early that change is difficult to 
establish when organizations and individuals in the organization are accustomed to practices 
being status-quo. Nursing is an innovate field of study which needs nurses who are willing to 
champion the challenge of change. For example, Fridman (2014) conducted a lived-experience 
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study about oncology nurse’s experiences with EBP project. During this project several themes 
were noted. A nurse stated that she felt empowered by the process of challenging the status 
quo; while, another was mesmerized by the EBP project process – she stated, she had never 
participated in an EBP project because she only had her bachelor’s degree. For example, 
schools of nursing could incorporate a class that pairs undergraduate senior students with a 
DNP student to collaborate on an EBP project. This will expose undergraduate students to the 
DNP process and prepare them to be the change agents nursing needs to incorporate research 
to practice. 
 In nursing graduate curricula, pharmacology and assessment classes can include a 
discussion about CPGs to prevent CVD in all patients. Students are then exposed to the idea of 
the PCE and the ability to download the application to their mobile devices. Doctor of nursing 
practice prepared students are in a unique position to learn about the health disparities that 
plague the community where they live. Service projects can be completed to combat, educate 
and empower individuals of the community to change to a healthy lifestyle. 
 An educational PowerPoint was used to provide a since of urgency and share the vision 
for this EBP project. The educational sessions were performed separately because the HCPs 
rotate between two offices. Initially, all team players were excited to be assisting in this EBP 
project. Questions were answered, and the PL was available to answer questions throughout 
the implementation phase and daily during the first week. Education about HCPs not adhering 
to CPGs, statistics about CVD, and CPG implementation strategies can be used in various 
formats. Various educational formats can be used by the DNP practitioner to provide education 
about the latest evidence-based CPGs. Educational formats available include PowerPoints in 
Health stream, face to face education, or lunch and educate. All staff members need to be 
included in the education about preventing primary CVD and the best strategies to create a 
successful change. If resistance occurs during the educational stage, it needs to be addressed 
at that time so that cohesiveness can be established, and all fears and hesitancies are 
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addressed. Successful implementation is curial, and it begins with education and getting all 
stakeholders on board. 
Conclusion 
 Computer-generated reminders printed on paper and provided to the HCP at point of 
care visits showed a 20% improvement in compliance with HCP prescribing a statin and/or 
aspirin to at-risk patients despite resistance by the gatekeeper. Clinical decision support 
systems and EMR alert systems have been shown to be the best intervention for HCPs to 
adhere to recommended guidelines. Results from this EBP project reveal that it is critical for 
DNP practitioners to use the best evidence available when conducting EBP projects. 
Organizations must remove factors which prevent the use of best practice by settling for other 
options, they may introduce unintended barriers to achieving the best possible patient care. The 
Kotter’s (2012) change model and PARiHS (Kitson et al., 1998) model was used to guide this 
EBP project to provide the necessary tools and guidance to bring this project to fruition 
successfully. When using Kotter (2012) 8-step change model, establishing a strong coalition 
who knows and understands the vision and goals of the EBP project is essential. Dependability, 
accountability, and responsibility lie with the gatekeepers and therefore, they are able to impede 
the progress of the EBP project. Successful implementation of an EBP project relies on the 
gatekeeper but more importantly the stakeholder’s willingness to incorporate the best evidence-
based practice for change to occur. 
It is imperative that the primary prevention of CVD is important to every DNP prepared 
practitioner. Doctor of nursing prepared practitioners must remain vigilant life-long learners 
because of the fast-paced innovative changes in healthcare. Education and knowledge about 
the latest evidence-based CPGs for the prevention of primary CVD in at-risk patients is 
essential. Doctor of nursing prepared practitioners must consider strategies to improve CPG 
implementation for improved patient outcomes.  
PREVENTING PRIMARY CVD: CPG COMPLIANCE  93 
 
93 
 
Doctor of nursing practice prepared nurses are empowered to make change occur for 
the betterment of their patients. These nurses must educate patients about risk factors for 
primary CVD and its prevention. Patients should have a choice about whether they would like to 
begin a new medication regimen once educated about mechanism of action, side effects, and 
lifestyle changes. Doctor of nursing practice prepared practitioners in congruence with the 
patient must provide effective and efficient care by using the latest EBP for the best patient 
outcomes. 
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Table 1A 
 
Summary of the Evidence 
Author(s), 
Year, 
Publication 
Purpose Method Setting/Sample Design Findings 
Analysis 
Level of 
Evidence 
Grade of 
Evidence 
Arditi, C., 
Rege-
Walther, M., 
Durieux, P., & 
Burnand, B. 
(2017).  
Cochrane 
Database of 
Systematic 
Reviews. 
To evaluate the 
effects of 
computer-
generated 
reminders 
delivered to 
HCPs on paper 
improved on 
quality of care 
and patient 
outcomes. 
Literature 
search of nine 
databases,  
Reference 
checking 
and citation 
chasing 
Sample:  
35 studies which 
focused on 
healthcare 
providers 
Systematic 
Review 
Computer-
generated 
reminders 
delivered on 
paper moderate-
certainty slightly 
improves quality 
of care by 6.8% 
in terms of 
guideline 
prevention and 
disease 
management 
guideline 
compliance. 
Reminders alone 
improved quality 
of care by 11%. 
Reminders with 
other 
interventions by 
4%.  
II A 
Fiks, A. G., 
Zhang, P., 
Localio, A. R., 
Khan, S., 
Grundmeier, 
R. W., 
Karavite, D. 
Characterize 
patterns of 
adoption of the 
clinical decision 
support (CDS), 
assess the 
impact of 
Reviewed 100 
charts 
Extracted  
Setting: 
Pediatric 
physician offices 
 
Sample: 
16 practices 
108 clinicians 
Prospective 
Cohort study 
and 
Comparison 
study 
CDS system was 
used 21% by 
clinicians and 
17% of eligible 
otitis media visits. 
Clinicians who 
received 
I A 
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J.,…Forrest, 
C. B. (2013).  
Health 
Research and 
Educational 
Trust  
performance 
feedback on 
adoption, and 
measure the 
impact of CDS 
use on guideline 
adherence.  
41,391 visits feedback 
adhered to CPGs 
increased 9.0% 
compared to 
others. 
Flodgren, G., 
Hall, A. M., 
Goulding, L., 
Eccles, M. P. 
Grimshaw, J. 
M., Leng, G. 
C., & 
Shepperd, S. 
(2016). 
Cochrane 
Database of 
Systematic 
Reviews  
Evaluated the 
effects of 
guideline 
implementation 
tools developed 
by producers of 
guidelines to 
improve usage of 
their guidelines. 
Systematic 
review of 
evidence from 
several 
database 
searches 
Sample:  
Healthcare 
professionals in 
all 4 studies 
Health system 
mangers  
Policy makers 
Systematic 
Review 
Tools created by 
guideline 
producers 
probably 
improves 
adherence and 
implementation of 
guidelines. 
I A 
Hendrix, K. 
S., Downs, S. 
M., Carroll, A. 
E. (2015). 
Academic 
Pediatrics. 
Does yellow 
highlighting 
prompts in a 
clinical decision 
support system 
improve the 
responsiveness 
of physicians. 
Physicians in 
two offices 
received 
CDSS 
generated 
yellow 
highlighted 
prompts  
 
2 offices 
prompts were 
not highlighted 
when 
presented to 
physicians. 
 
Setting: 
4 urban primary 
care pediatrician 
clinics 
 
Sample: 
7 prompts 
included for 
randomization 
 
4 high-priority 
non-randomized 
prompts were 
highlighted each 
time 
RCT 2237 randomized 
prompts 
 
62% did not 
respond to 
highlighted 
prompts 
 
61% did not 
respond to 
prompts not 
highlighted 
 
There was not 
statistical 
difference in 
I A 
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High priority 
prompts were 
always 
highlighted 
responsiveness 
of physicians 
from highlighting 
prompts or high 
priority reminder 
prompts and not 
highlighting 
prompts. (OR 
1.056; 95% CI; 
P= .259). 
  
Ivers, N., 
Jamtvedt, G., 
Flottorp, S., 
Young, J. M., 
Odgaard-
Jensen, J., 
French, S. 
D.,…Oxman, 
A. D. (2012). 
Cochrane 
Database of 
Systematic 
Reviews. 
  
To assess the 
effects of audit 
and feedback on 
the practice of 
healthcare 
professionals 
and patient 
outcomes and to 
examine factors 
that may explain 
variation in the 
effectiveness of 
audit and 
feedback. 
Literature 
search of 
several 
databases 
Sample: 
140 Audit and 
feedback RCTs 
 
Healthcare 
professionals 
responsible for 
patient care. 
Postgraduate 
healthcare 
professionals 
Systematic 
Review 
Small 
improvements in 
professional 
practice were 
found with audit 
and feedback. 
Improvement 
pertained to the 
baseline 
performance and 
feedback was 
provided. 
I A 
LI, Y. (2018). 
Joanna 
Briggs 
Institute 
What is the best 
available 
evidence 
regarding the 
effectiveness of 
audit and 
feedback in 
promoting 
evidence 
implementation?  
Searching the 
literature and 
databases for 
systematic 
reviews which 
focused on 
audit and 
feedback. 
N/A Systematic 
Review 
After carefully 
considering 
practitioners audit 
and feedback by 
itself or cohabited 
with other 
strategies can 
elicit change in 
practice among 
practitioners.  
I A 
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Regan, M. E. 
(2017).  
Journal of 
American 
Association of 
Nurse 
Practitioners 
Develop an 
evidence-based 
quality 
improvement 
intervention for 
primary care 
providers (PCP) 
through the 
delivery of 
evidence-based 
guidelines at 
point-of-care. 
An algorithm 
and chronic 
kidney disease 
(CKD) tool was 
developed in 
the EMR 
based on the 
NKF-KDOQI 
guidelines and 
supporting 
evidence. 
 
Pre-
intervention: 
Knowledge 
surveys and 
baseline data 
was collected. 
Chronic kidney 
disease 
educational 
intervention 
and tutorial on 
clinical 
decision 
support tool 
was presented 
to participants 
then sent via 
email. 
 
A go live 
reminder email 
was sent. 
 
Setting: 
PCP offices 
 
Sample: 
11 PCP offices 
80 PCPs 
• 55 
physicians 
• 17 NPs 
• 8 PA’s 
Comparison 
study 
 
 
Survey’s: 19 
PCP’s did not 
take the pretest 
and baseline 
survey. 
 
Knowledge: 
increased 
Lab diagnostic 
(Z=-2.00, p=.046) 
 
CKD stage 
interpretation 
(Z=-2.83, p=.005) 
 
CKD patient 
assessment (Z= -
2.41, p=.024) 
 
No significant 
change between 
CKD familiarity 
scores (p > .05) 
 
III B 
PREVENTING PRIMARY CVD: CPG COMPLIANCE  109 
 
109 
 
Rokstad, I., 
S., Rokstad, 
K. S., 
Holmen, S., 
Lehmann, S., 
Assmus, J. 
(2013). 
Scandinavian 
Journal of 
Primary 
Health Care 
Does 
incorporating an 
electronic 
optional 
guideline tool in 
the standardized 
referral template 
used by general 
practitioners 
when referring 
patients to 
specialized care 
could improve 
outpatient 
referral 
appropriateness? 
Electronic 
optional 
guideline tool 
was created 
for referral 
 
Inclusion: 
Sleep apnea 
Chronic 
obstructive 
pulmonary 
disease 
Lung tumors of 
the lung 
Setting: 
Bergen and the 
Department of 
Thoracic 
Medicine at 
Haukeland 
University 
Hospital 
 
Sample:  
210 general 
practitioners (GP) 
 
Intervention 
group:  
93 GPs 
 
Control group: 
117 GPs 
 
Intervention 
Study 
The intervention 
yielded 1080 new 
referrals of which 
70% were from 
GPs. 
Time: 
34% shorter in 
the intervention 
group – 82 used 
of these used the 
tool. 
II B 
Shojania, K. 
G., Jennings, 
A., Mayhew, 
A., Ramsay, 
C.R., Eccles, 
M. P., & 
Grimshaw, J. 
(2009).  
Cochrane 
Database of 
Systematic 
Reviews. 
To evaluate the 
effects on 
processes and 
outcomes of care 
attributable to 
on-screen 
computer 
reminders 
delivered to 
clinicians at the 
point of care. 
Literature 
search of 
several 
database and 
bibliographies 
of key articles. 
Sample:  
28 studies 
RCT 
Quasi-RCTs 
Systematic 
Review 
4.2% 
improvement on 
adherence to 
computer 
reminders 
3.3% medication 
ordering 
3.8% 
vaccinations 
3.8% for testing 
 
Computer-
generated 
reminders at 
point of care has 
a small to modest 
II A 
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improvement in 
provider 
behavior. 
 
Zahanova, S., 
Tsouka, A., 
Palmert, M. 
R., & 
Mahmud, F. 
(2017).  
Canadian 
Journal of 
Diabetes. 
Evaluate the 
impact of a 
computerized 
point-of-care 
decision support 
system on 
clinical practice 
guideline 
knowledge and 
adherence. 
iSCREEN 
used as a 
clinical 
decision 
support system 
integrated into 
the electronic 
health record 
as a reminder 
to clinicians of 
diabetic 
patients. 
 
Retrospective 
chart review of   
and 
questionnaire 
pre- and post-
implementation 
 
A total of 50 
charts was 
reviewed (25 
prior and 25 
post iSCREEN 
integration. 
 
Setting:  
Diabetic clinic 
 
Sample: 
50 adolescents’ 
charts 
Retrospective 
study 
Surveys 
collected: 58 
 
Pre-intervention 
31  
Post-intervention 
27 
Questions 
Knowledge: 
Pre 
 
Post-intervention 
11% 
improvement in 
overall scores 
(p=0.06) 
 
Utilizing current 
resources: 
5-point Likert 
scale 
 
Nephropathy 
(p=0.03) and 
retinopathy 
(p=0.04) initial 
screening 
increased and 
under and over 
screening 
decreased. 
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No change in 
thyroid function 
test screening or 
dyslipidemia. 
 
Appropriated 
HTN screening at 
baseline 
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Appendix B 
Clinical practice guideline flowsheet 
 
 
 
Figure 4. Initiating Statin Therapy in Individuals Without Clinical ASCVD. Colors correspond to the Classes of Recommendation in 
Table 1. *Fasting lipid panel preferred. In a nonfasting individual, a non–HDL-C level ≥220 mg/dL could indicate genetic 
hypercholesterolemia that requires further evaluation or a secondary etiology. If nonfasting triglycerides are ≥500 mg/dL, a fasting 
lipid panel is required. †The Pooled Cohort Equations can be used to estimate 10-year ASCVD risk in individuals with and without 
diabetes. A downloadable spreadsheet enabling estimation of 10-year and lifetime risk for ASCVD and a Web-based calculator are 
available at http://my.americanheart.org/cvriskcalculator and http://www.cardiosource.org/en/Science-And-Quality/Practice-
Guidelines-and-Quality-Standards/2013-Prevention-Guideline-Tools.aspx. ‡For those in whom a risk assessment is uncertain, 
consider factors such as primary LDL-C ≥160 mg/dL or other evidence of genetic hyperlipidemias; family history of premature 
ASCVD with onset <55 years of age in a first-degree male relative or <65 years of age in a first-degree female relative, high-
sensitivity C-reactive protein ≥2 mg/L; CAC ≥300 Agatston units or ≥75th percentile for age, sex, and ethnicity (for additional 
information, see http://www.mesa-nhlbi.org/CACReference.aspx); ABI <0.9; or lifetime risk of ASCVD. Additional factors that may 
aid in individual risk assessment could be identified in the future. §1) Potential ASCVD risk-reduction benefits. The absolute 
reduction in ASCVD events from moderate- or high-intensity statin therapy can be approximated by multiplying the estimated 10-
year ASCVD risk by the anticipated relative-risk reduction from the intensity of statin initiated (~30% for moderate-intensity statin or 
~45% for high-intensity statin therapy). The net ASCVD risk-reduction benefit is estimated from the number of potential ASCVD 
events prevented with a statin, compared to the number of potential excess adverse effects. 2) Potential adverse effects. The 
excess risk of diabetes is the main consideration in ~0.1 excess cases per 100 individuals treated with a moderate-intensity statin 
for 1 year and ~0.3 excess cases per 100 individuals treated with a high-intensity statin for 1 year. In RCTs, both statin-treated and 
placebo-treated participants experienced the same rate of muscle symptoms. The actual rate of statin-related muscle symptoms in 
the clinical population is unclear. Muscle symptoms attributed to statin therapy should be evaluated (see Table 8, Safety 
Recommendation 8). ABI indicates ankle-brachial index; ALT, alanine transaminase; ASCVD, atherosclerotic cardiovascular 
disease; CAC, coronary artery calcium; CK, creatine kinase; FH, familial hypercholesterolemia; LDL-C, low-density lipoprotein 
cholesterol; MI, myocardial infarction; RCT, randomized controlled trial; and ULN, upper limit of normal. 
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